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resumo 
 
 
A proteína precursora de amilóide de Alzheimer (APP) é um factor chave na 
doença de Alzheimer (AD). Essencialmente o processamento da APP resulta 
na produção de Abeta, o peptídeo tóxico depositado nas placas de amilóide 
dos indivíduos com AD. Ainda permanece por esclarecer se o processamento 
da APP é afectado sob condições de stress celular, potencialmente 
aumentando a quantidade de Abeta produzida. Além disso, o stress celular 
pode induzir alterações moleculares, associadas à AD, que podem representar
marcadores moleculares úteis para o diagnóstico da AD.  
Com estas questões em mente, procurámos identificar alterações, em resposta 
ao stress celular, no processamento da APP e na expressão de outras 
proteínas. Nestes estudos de monitorização considerámos que a fosforilação 
proteica anormal e o stress oxidativo podem contribuir para a condição 
patológica. Assim, investigámos o processamento da APP dependente da 
fosforilação durante o stress celular. Os dados obtidos confirmam que a 
secreção da APP é reduzida em situações de stress, e que o efeito é idêntico 
em linhas celulares de tipo neuronal e não neuronal. Os resultados obtidos 
revelam que o PMA, mesmo em situações de stress (azida de sódio 1 mM) 
pode afectar o processamento da APP, aumentando a produção de sAPP (o 
fragmento secretado após o processamento de APP) que pode potencialmente 
reduzir a produção de Abeta. A hipótese de afectar a produção de Abeta 
dependente da fosforilação, que por sua vez pode ter relevância num quadro 
clínico, mantém-se mesmo em condições de stress.  
Os resultados revelaram que a indução de sAPP, após a adição de ésteres de 
forbol, ou ácido ocadeíco, em condições de stress não é idêntica. Em 
contraste, sob condições controlo, tanto os ésteres de forbol como o ácido 
ocadeíco produzem o mesmo efeito em termos da produção de sAPP. 
Aparentemente estas duas vias podem ser dissociadas em condições de 
stress, o que de algum modo pode reflectir processamento alterado da APP 
em condições adversas. 
Nas experiências em que se analisou a expressão de outros potenciais 
marcadores moleculares, foram detectadas alterações nos níveis de expressão 
de várias proteínas. Estes marcadores moleculares representam alvos 
interessantes para futura validação e potenciais candidatos para um 
diagnóstico molecular na AD. As proteínas já identificadas são importantes do 
ponto de vista da transdução de sinais, e incluem a PP1, a HSP70, a PARP e 
a própria APP. 
 
 
   
 
  
 
abstract 
 
The Alzheimer’s amyloid precursor protein (APP) is a key factor in Alzheimer’s 
disease (AD).  Essentially the processing of APP results in the production of 
Abeta, a toxic peptide found deposited in the amyloid plaques of individuals 
with AD.  It is unclear whether under conditions of cellular stress APP 
processing is affected, potentially increasing the amount of Abeta being 
produced.  Further the molecular alterations induced by cellular stress, and 
associated with AD, could present attractive molecular markers for the 
diagnosis of AD. 
Bearing these questions in mind we set out to identify cellular stress-related 
alterations in APP processing and altered expression of APP and other 
proteins. When monitoring potential molecular markers we had in mind several 
findings describing that both abnormal protein phosphorylation and oxidative 
stress can contribute to the disease condition. Thus, we investigated 
phosphorylation-dependent APP processing during cellular stress. The data 
confirmed that APP secretion is reduced under stress, and that the effect is 
similar in both neuronal like and non-neuronal cell lines.  The present results 
reveal that PMA, even under stress conditions (1 mM sodium azide), can affect 
APP processing, increasing sAPP (a fragment secreted following the 
processing of APP) production which can potentially reduce Abeta production. 
The hypothesis whereby affecting Abeta production in a phosphorylation-
dependent manner and that this may be of clinical relevance appears to hold 
true even under stress conditions.  
The results also revealed that induction of sAPP upon addition of phorbol 
esters, or okadaic acid, under conditions of stress was not the same.  This 
contrasts markedly with control conditions where both phorbol esters and 
okadaic acid produce the same effect in terms of inducing sAPP production. 
Hence, it appears that these pathways can be dissociated under conditions of 
stress, which may in fact reflect altered APP processing during adverse 
conditions.   
In the experiments addressing the expression levels of other potential 
molecular markers, alterations in apparent expression levels of several proteins 
could be detected. These molecular markers provide interesting targets for 
further validation and potential candidates for a future molecular diagnosis of 
AD. Proteins thus far identified are important from a signal transduction point of 
view and they include, protein phosphatase1, HSP70, PARP and APP itself. 
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1.1  Alzheimer´s Disease 
 
Alzheimer´s disease (AD), first described by the German pathologist Alois 
Alzheimer in 1907 (Alzheimer, 1907), is presently the most common 
neurodegenerative disease among the eldery. This disorder of the central nervous 
system (CNS) can occur in people in their 40s and 50s, but it most often affects 
those in their 60s and older. AD is a form of dementia that invariably leads to a 
complete loss of all cognitive abilities and premature death. Individuals affected 
by AD exhibit a progressive deterioration of memory and logical thinking. In the 
later stages perception and orientation are affected as well as loss of personality 
and intellect to an extent that interferes with daily activities. 
 
1.1.1  Neuropathological hallmarks of Alzheimer´s Disease 
 
Prominent histopathological features of this disease include the 
extracellular deposition of insoluble amyloid deposits – senile plaques – in the 
brains of affected individuals and also the accumulation of intracellular 
neurofibrillary tangles (NFT) (Grundke-Iqbal et al., 1986; Goedert et al., 1992) 
(Figure 1). NFT contain aggregates of proteins, mainly composed of 
hyperphosphorylated tau protein. In AD, the latter is present as insoluble filaments, 
usually paired helical filaments. Tau is a microtubule-associated protein which is 
normally quite soluble and the cellular events that result in filament formation are 
not well understood. A key normal function of tau is to promote the bundling of 
neurofilaments in axonal processes of neurons. The extent to which tau promotes 
this activity depends on its phosphorylation. Hence, changes in the activation of 
signalling cascades leading to abnormal phosphorylation or aberrant tau 
aggregation can potentially contribute to the formation of NFT resulting in 
neuronal degeneration.  
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Figure 1. Hallmarks of Alzheimer´s Disease. Left Panel: Silver stain of a senile plaque. The major 
component of the plaque is the amyloid Abeta peptide. Right Panel: silver stain shows dark–staining 
NFT in individual neurons. In AD tau becomes hyperphosphorylated changing the structure of 
neurofilaments. Although the senile plaques and the NFT are pathological hallmarks of AD, many 
elderly persons have small numbers of these structures in their brains without manifesting the disease. 
(Taken from www.medsch.wisc.edu/path703/slide/lectslides/cnsdegen.html). 
 
As already mentioned, another neuropathological hallmark of the disease 
is the presence of senile plaques in the brain. These extracellular deposits of fibrillar 
aggregates are mainly composed of a 4-KDa peptide termed beta-amyloid 
(Abeta) (Glenner and Wong, 1984). Abeta is a proteolytic fragment derived from 
the Alzheimer´s amyloid precursor protein (APP) and although Abeta exists as an 
aggregated, poorly soluble form in brain deposits, it is secreted from cells during 
normal metabolism as a soluble molecule (Haass et al., 1992; Shoji et al., 1992). 
The principals underlying cellular features of AD are the degeneration and 
eventual loss of neuronal cells. This extensive degeneration affects many types of 
neurons and may account for the numerous neurological deficits shown by 
affected individuals. Neurodegeneration is most pronounced in the hippocampus, 
cerebral cortex and amygdala (Price et al., 1993; Williams, 2001), regions of the 
brain that play a major role in memory, cognition and behaviour. However, the 
relationship and all the sequential factors that result in NFT, senile plaques, and 
finally in AD have not been fully described or understood. Nonetheless it is clear 
that AD is a multifactorial disorder which includes genetic risk factors, abnormal 
protein processing and external factors such as cellular stress. 
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1.1.2  Genetic risks for Alzheimer Disease  
 
Approximately 95% of AD cases are sporadic and appear at a late age, 
while the remaining 5% of cases have an autossomal dominant pattern of 
inheritance. The AD cases of genetic etiology are termed familial Alzheimer´s 
disease (FAD). Familial history of dementia is a risk factor in AD but several other 
aspects may influence the development of the disease (Richard and Amouyel, 
2001). Although only a small portion of AD cases have a genetic basis, the 
molecular and genetic study of these familial cases allows for increased 
knowledge about the etiology of the more abundant sporadic forms, since 
increased Abeta production and accumulation is a common feature of both. 
Genetic analyses have led to the identification of three “causative” genes 
for early-onset FAD (?  60 years): APP on chromosome 21, presenilin 1 (PS1) on 
chromosome 14, and presenilin 2 (PS2) on chromosome 1.  
Within the APP gene various locations carrying mutations (Figure 2) have 
been identified (Chartier-Harlin et al., 1991; Goate et al., 1991; Hardy and Allsop, 
1991; Murrell et al., 1991; Mullan et al., 1992). These mutations result in a single 
amino acid substitution [or a double amino acid substitution (Lys595, Met596 ?  Asn, 
Leu; see Figure 2), namely in the Swedish mutation]. Significantly, mutations in APP 
(all lying near or within the Abeta domain) associated with FAD result in APP being 
more efficiently processed by secretases, thus generating increased amounts of 
Abeta (Citron et al., 1992, Cai et al., 1993, Haass et al., 1995), thereby promoting 
amyloidogenesis. Furthermore, the level of APP being expressed also appears to 
be an important aspect. For instance, in Down’s Syndrome, caused by trissomy of 
chromosome 21, there is an extra copy of the APP gene. These individuals show 
increased levels of Abeta and invariably develop plaques and tangles in their 
brains, with clinical dementia in many cases before the age of 50 (Tanzi et al., 
1987; Selkoe 1997; Esler and Wolfe, 2001). 
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Figure 2. APP mutations lying near or in the Abeta domain. The Figure shows APP with the Abeta 
domain and the cleavage sites of the secretases involved in APP processing. Residues in blue 
indicate genetic mutations already described. 
 
Overall, APP mutations are responsible for only a small number of FAD cases 
(Tanzi et al., 1992). The majority of early-onset cases have been associated with 
mutations in PS1 and PS2, that are known to regulate APP processing (De Strooper 
et al., 1998). More importantly, presenilin mutations linked to FAD all increase 
processing of APP and Abeta formation (Duff et al., 1996; Scheuner et al., 1996; 
Selkoe, 1997). AD is clearly a multifactorial disorder, where genetic predisposition 
also plays a relevant role. Apolipoprotein E (ApoE) is an inherited “risk factor” for 
late-onset FAD (?  60 years) on chromosome 19 (for review see Tanzi et al., 1996). 
Allelic variation of ApoE is an important contributing factor for sporadic AD cases, 
since apolipoprotein E binds to Abeta, potentially affecting the formation of senile 
plaques (Selkoe, 1997; Holtzman, 2001).  
In all FAD cases there is evidence for excessive secretion of Abeta and both 
genetic and sporadic cases exhibit Abeta deposition in brain parenchyma and 
blood vessels (Iwatsubo et al., 1994; Wang et al., 1999), that invariably leads to the 
development of AD. This observation, coupled with studies demonstrating that 
Abeta is neurotoxic to neurons (Yankner et al., 1990; Kowall et al., 1992; Pike et al., 
1992; Butterfield, 1997), led to the concept that Abeta is central to the 
pathogenesis of AD.  
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Abeta 1-40
? -secretase ?-secretase?-secretase
NH2 COOH
Lys595 Met596 to Asn Leu
1 40 42
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1.1.3  Alzheimer´s amyloid precursor protein and Abeta genesis 
 
Abeta arises from the intracellular processing of APP, which is encoded by 
a gene on chromosome 21 and is constitutively secreted by both neuronal and 
non-neuronal mammalian cells into the extracellular fluid (Selkoe, 1994). APP is an 
integral transmembrane glycoprotein containing a membrane-spanning domain 
(Kang et al., 1987; Tanzi et al., 1987). Several functions for APP and its derivates 
have been described (Buxbaum and Greengard, 1996; Kosik et al ., 1996; Selkoe et 
al., 1996), including cell-surface receptor (possible GO coupled) involved in signal 
transduction, protease inhibition, cell adhesion molecule, regulation of neuritic 
outgrowth, promotion of cell survival, protection against a variety of neurotoxic 
insults, stimulation of synaptogenesis, modulation of synaptic plasticity, and in 
learning and memory processes (Mattson et al ., 1997; Dodart et al ., 2000).  
Alternative post-transcriptional splicing of the APP gene produces different 
isoforms of this protein ranging from 365-770 amino acid residues (Kosik, 1993). The 
three major isoforms expressed in the brain have 695, 751 and 770 amino acids 
(APP695, APP751 and APP770, respectively). The 751- and 770- amino acid spliced 
isoforms contain a Kunitz-type serine protease inhibitor (KPI), which may regulate 
the degradation of APP (Edelberg and Wei, 1996). APP695, the most abundant 
isoform expressed in neurons, lacks the KPI (Goedert, 1987; LeBlanc et al., 1991). 
APP is both N- and O-glycosylated (Weidemann et al., 1989) in its mature form 
while immature APP is N-glycosylated only. Protein glycosylation appears to play a 
key role in APP processing and function (Pahlson and Spitalnik, 1996). 
APP metabolism is complex and can occur via several pathways (Nitsch et 
al., 1994; Checler, 1995; Selkoe et al., 1996) which have not been fully elucidated. 
In its simplest form APP processing can be described as occurring via two major 
pathways, one being non-amyloidogenic and the other amyloidogenic (Figure 3). 
In the non-amyloidogenic (or ? -secretase) pathway, the ? -secretase enzyme 
cleaves APP within the Abeta domain and therefore prevents its production. The 
produced soluble N-terminal APP fragment is termed sAPP?  and further 
degradation of the C-terminal fragment by a ?-secretase, gives rise to a small 
fragment termed p3. The amyloidogenic (or ?-secretase) pathway involves a ?-
secretase enzyme which cleaves APP N-terminally to Abeta, and a subsequent ?-
secretase cleavage liberating Abeta peptides of 40 or 42 amino acids that can 
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aggregate and form senile plaques. The latter pathway also generates a soluble 
APP N-terminal fragment termed sAPP?  (Figure 3). However, this classification 
scheme appears to be an oversimplification, as N-terminal truncated Abeta 
peptides such as p3 have been isolated from early-stage diffuse plaques and form 
amyloid fibrils even more readily than full-length Abeta (Gowing et al ., 1994; Pike 
et al., 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. APP Processing. APP can be processed by two major pathways: the amyloidogenic 
pathway that gives rise to the toxic Abet a fragment, which can aggregate and form senile plaques, 
and the non-amyloidogenic pathway, which releases a small peptide known as p3.  
 
Moreover, considerable work has been dedicated to identifying all the 
secretases involved in these pathways. Likely candidates include two ezymes in a 
disintegrin and metalloprotease (ADAM) family: ADAM10 and ADAM-12 [or TACE ?  
tumor necrosis factor-?  (TNF-? ) converting enzyme] having either inherent ? -
secretase activity or are thought to be somehow involved in the regulation of ? -
secretase (Buxbaum et al ., 1998; Sabo et al ., 1999).  
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BACE1 (?-site APP-cleaving enzyme) also denominated Asp2 or memapsin 
2 has been identified as a ?-secretase, since it demonstrates all the properties of 
this enzyme, being responsible for the first step in the process that ultimately result 
in Abeta formation (Vassar et al., 1999). Moreover, intracellular localization of 
BACE1 is consistent with the generation site of Abeta. 
 
1.1.4  A new avenue for neuronal signalling transduction in Alzheimer’s 
Disease 
 
Recent evidence from several groups suggests that the generation of 
signalling proteins by “regulated intramembrane proteolysis” (RIP) is a new 
paradigm of signal transduction (Ebinu and Yankner, 2002). RIP occurs when a 
transmembrane protein is cleaved within the transmembrane domain, releasing a 
cytoplasmic fragment that can act directly in the nucleus to activate gene 
expression. This occurs in two steps. Cleavage of the protein outside the 
membrane (usually in response to ligand binding) results in a conformational 
change, which in turn triggers a second intramembrane cleavage event that 
releases an active cytoplasmic fragment. The latter translocates to the nucleus 
and activates gene expression (Ebinu and Yankner, 2002). 
The discovery that APP is one of the mammalian proteins that may be 
processed by RIP is extremely interesting and opens new avenues towards our 
understanding of the diverse signal transduction pathways (Selkoe and Kopan, 
2003). Intramembranous gamma-secretase cleavage of APP plays a central role 
in the formation of Abeta peptide. An intriguing possibility is that the cognate C-
terminal fragment generated by gamma-secretase cleavage could also play a 
role through the regulation of nuclear signalling events. Thus, RIP may contribute to 
both brain development and degeneration and may provide unexpected 
diversity to the signalling repertoire of a cell (Ebinu and Yankner, 2002). 
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1.2  Protein phosphorylation and Alzheimer´s Disease 
 
1.2.1  Phosphorylation dependent APP metabolism 
 
Of particular interest is the observation that APP metabolism via different 
pathways is phosphorylation dependent. Accordingly, several groups have shown 
that sAPP release into cell medium can be increased upon addition of phorbol 
esters. Although the factors affecting APP metabolism/processing have not been 
fully elucidated, it is now widely accepted that phosphorylation of APP itself could 
play an important role. Although this has yet to be clearly demonstrated, several 
kinases and phosphatases have been described as key players relevant to APP 
processing. A strong case has been made for protein kinase C (PKC) in the 
regulation of APP processing both in vitro (Nitsch and Growdon, 1994) and in vivo 
(Caputi et al., 1997; Savage et al., 1998). Direct activation of PKC by phorbol 
esters has been shown to regulate APP cleavage in several cell lines (Buxbaum et 
al., 1990; Gabuzda et al., 1993; Jacobsen et al., 1994; Nitsch et al., 1996; Mills et al., 
1997; Mills and Reiner, 1999). In vitro, the levels of Abeta ?produced can be 
decreased and the amounts of sAPP produced via the ? -secreatase pathway 
increased upon the addition of PDBu (Buxbaum et al, 1993; Caporaso et al, 1992). 
Observations that APP could be phosphorylated both in vitro (Gandy et al, 1988, 
Suzuki et al, 1994) and in vivo in rat brain and several cell lines (Oishi et al., 1997) 
on the cytoplasmic domain on residues Thr654 and Ser655, made it a strong 
candidate as a substrate for the above mentioned activity. However, it is known 
that PDBu-stimulated release of sAPP can occur independently of the 
phosphorylation state of APP. Indeed, direct phosphorylation of APP by PKC is not 
required because the deletion of the cytoplasmic tail of APP did not inhibit the 
increase in the release of sAPP elicited by phorbol esters (da Cruz e Silva et al., 
1993; Hung and Selkoe, 1994). Hence, the action of PKC, promoting ? -secretase 
cleavage has not been fully elucidated. 
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1.2.2  Protein phosphatases in Alzheimer´s Disease 
 
Protein phosphatases are also important in APP processing and in the 
phosphorylation of Tau protein. The three most common types of Ser/Thr-
phosphatases are protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A) 
and protein phosphatase 2B (PP2B). PP2A, PP2B, and to a less extent, PP1 can all 
dephosphorylate Tau in vitro (Gong et al., 2000). 
PP1, the most widely expressed and abundant protein Ser/Thr-phosphatase, 
is likely to play a central role in the production of sAPP, since the half-maximal 
dose for stimulation of APP secretion was approximately 100-fold higher with 
okadaic acid (OA, an inhibitor of serine/threonine specific protein phosphatases) 
than with calyculin A (da Cruz e Silva et al., 1995a). Similarly, exposing a rat brain 
cell line to Abeta, Tan et al. (1997), showed that one 50-60 KDa protein became 
more phosphorylated. Furthermore, using several kinase and phosphatase 
inhibitors they could block both increase phosphorylation of this protein and 
Abeta toxicity. Additionally, Abeta also causes a general increase in overall 
phosphatase activity. It is therefore likely that a protein phosphorylation cascade 
is involved in Abeta toxicity (Tan et al., 1997). 
Moreover, PP1 is known to be highly expressed in adult mammalian brain 
both in neurons and glia (da Cruz e Silva et al., 1995b; Ouimet et al., 1995). 
Although ubiquitously expressed throughout the periphery, the three known PP1 
catalytic subunits (PP1alpha, PP1beta and PP1gamma) are particularly abundant 
in mammalian brain. PP1 has been linked to the efficacy of learning and memory 
by limiting the acquisition of new knowledge and favouring memory decline 
(Genoux et al., 2002). PP1 inhibition prolongs memory when induced after 
learning, suggesting that PP1 promotes “forgetting”. These findings may account 
for age-related cognitive decline and emphasize the physiological importance of 
PP1 as a suppressor of learning and memory. Thus, at least in mice, the molecular 
machinery is not completely deteriorated with aging and the results show that 
near normal cognitive functions can be restored by simply inhibiting PP1. It would 
appear therefore that altered PP1 activity may be associated with normal 
cognitive decline during aging and represents an important molecule to monitor 
in AD related studies. 
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1.3  Oxidative stress associated events in Alzheimer´s Disease 
 
As previously mentioned, AD is a multifactorial disease, at the centre of 
which lies a cascade of biochemical events which can contribute to the 
pathogenesis of the disease condition. Oxidative stress is such a contributing 
factor which has received considerable attention. Indeed, oxidative stress is 
extensive in the AD brain (Markesbery, 1997, Markesbery and Carney, 1999; Smith 
et al., 2000), and occurs when the generation of reactive oxygen species (ROS) 
exceeds intrinsic antioxidant defences of living cells.  
 
There is evidence that oxidative damage, mediated by free radical injury, 
may be one of the initiating and promoting factors responsible for 
neurodegeneration in AD (Prasad et al., 2002). Further, oxidative stress precedes 
plaque and tangle formation, as demonstrated using transgenic animals bearing 
mutations leading to plaque formation (Pratico et al., 2001, reviewed in Gibson, 
2002). Although the initial sources of oxidative stress remain unclear, the process 
seems highly dependent on the four aspects described below: 
 
1) Active microglia around senile plaques. An oxidative inflammatory 
response can be initiated due to the release of reactive oxygen intermediates, 
nitric oxide and inflammatory cytokines by activated microglia triggered by Abeta 
deposits (Colton and Gilbert, 1987; Lukiw and Bazan, 2000; Butterfield et al ., 2001). 
 
2) Redox-activity of transition metals such as iron and copper (Perry et al., 
2002). The levels of iron (in a redox-active state) are increased in NFTs as well as in 
Abeta deposits (Smith et al., 1997), iron catalyses the production of radical 
hydroxyl from H2O2. Furthermore, aluminium, which also accumulates in NFT 
containing neurons, stimulates iron induced lipid peroxidation. 
 
3) Mitochondria and metabolic enzyme dysfuntion. Abnormalities of the 
mitochondrial genome or deficiencies of key metabolic enzymes contribute to 
metabolic impairment and ROS production (Davis et al., 1997; Blass et al., 1990). 
Metabolic changes are linked to production of ROS and to changes in cellular 
calcium regulation. Production of ROS is a normal part of the electron transport 
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chain, and impairment of electron transport (for instance due to inhibition of 
cytochrome oxidase) promotes ROS production. 
 
4) Abeta itself. An increased number of studies support a central role of 
Abeta as a molecular link between oxidative stress and AD associated neuronal 
death (Butterfield, 1997; Varadarajan et al., 2000), and this will be discussed 
below. 
 
In fact, almost all factors that contribute to oxidative stress are indirectly or 
directly related to Abeta production or deposition. Hence, it is evident that the 
genetic mutations mentioned above and other mechanisms (ApoE genotype and 
redox metal ions) which result in increased Abeta deposition, can contribute to 
Abeta induced oxidative stress and neurotoxicity (Lauderback et al., 2002; 
Butterfield et al ., 2001).  
As already mentioned, Abeta can trigger the inflammatory response 
induced by astrocytes and activated microglia that may be critical for the 
neurodegenerative process in AD (Figure 4). Rat neuronal-glial cultures exposed to 
Abeta exhibit increased levels of inducible nitric oxide synthase (iNOS) and nitric 
oxide (NO) release (Hu et al., 1998; Haas et al., 2002). The latter interacts with 
superoxide anion forming other free radical, peroxynitrite, which, beside other 
effects, attacks lipids producing lipid peroxidation (that essentially affects the 
stability of the membranes). Therefore peroxynitrite can cause oxidative damage 
of synaptic terminals (Butterfield et al ., 2002). 
Similarly, Abeta peptides can enhance metal-catalyzed oxidation reactions 
(Dikalov et al., 1999; Yatin et al., 1999), insert into neuronal membranes and initiate 
free radical damage resulting in protein oxidation, lipid peroxidation, ROS 
formation, and cellular dysfunction. These processes also produce calcium ion 
accumulation and subsequent neuronal death (Varadarajan et al., 2000; 
Butterfield et al., 2001) (Figure 4). Abnormalities in cellular calcium storage affect 
the ability of cells to handle oxidative stress and to respond to metabolic 
impairment, a characteristic associated with AD (reviewed in Gibson, 2002).   
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Figure 4. Neurodegenerative process in Alzheimer´s disease. Central role of Abeta in oxidative 
stress and  neurotoxicity (adapted from Butterfield et al., 2001). 
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Moreover, Abeta leads to oxidative modification and inhibition of several 
neuronal and glial transmembranes transport systems, such as ion-motive ATPases, 
glutamate receptors, glucose transporters, GTP-coupled transmembrane 
signalling proteins and polyamine transporters (Mattson, 1999; Lauderback et al., 
2001; Yatin et al., 2001). Loss of each transport systems has deleterious 
consequences for the neurons, including loss of cellular membrane potential, 
accumulation of excitotoxic glutamate, decreased glucose availability, 
decreased intracellular communication and increased neurotoxicity.   
Furthermore, several studies have implicated mitochondrial defects in the 
pathogenesis of AD (Gabuzda et al., 1994; Prasad et al ., 2002). Defective 
mitochondria lead to reduced production of ATP which results in decreased 
energy metabolism. For example, decreased glucose uptake coupled with 
reduced activity of cytochrome oxidase (complex IV) results in increased 
production of ROS by impaired mitochondria (Mutisya et al., 1994).  
As already mentioned, Abeta itself can directly induce the formation of 
free radicals (Varadarajan et al., 2000, Varadarajan et al., 2001) but it can also 
increase levels of ROS in cells, such as H2O2 (Behl et al., 1994; Huang et al., 1999). 
These increased levels of H2O2 interfere with glucose metabolism, by inhibiting the 
activity of metabolic enzymes involved in this process (such as pyruvate 
dehydrogenase, ? -ketoglutarate dehydrogenase enzyme complex and 
transketoloase) (Chinopoulos et al., 1999; Gibson et al., 2000; Xu et al.; 2001, 
Gibson, 2002). A general reduction in glucose uptake also increases ROS 
production. 
Although, there is evidence that Abeta can contribute to the increased 
production of oxidative stress in AD, it is noteworthy that oxidative stress and 
metabolic compromise can lead to altered APP processing resulting in Abeta 
formation. In fact, oxidative stress induced by H2O2 increases Abeta in mammalian 
lens (Frederikse et al., 1996) and SHSY5Y cells (Misonou et al., 2000; Olivieri et al., 
2001). Several reports have analyzed the effect of the metabolic impairment due 
to inhibition of cytochrome c oxidase (which results in superoxide anion formation) 
by sodium azide on APP processing. Gasparini et al . (1997) showed that sodium 
azide decreased APPs production from COS-1 cells, and Gabuzda et al. (1994) 
showed that it resulted in the production of a 11.5 KDa C-terminal fragment, 
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potentially containing the full length Abeta sequence, using COS 1 cells 
transfected with APP695. In both studies increased levels of the toxic Abeta peptide 
was implicated. Thus, these results can provide a potential framework to link the 
reported cytochrome c oxidase deficits in AD (Gibson et al., 1996; Kish et al., 1992; 
Parker et al ., 1994) and the accumulation of Abeta peptides (Vickers et al ., 2000). 
Taken together, this data suggests a strong correlation between Abeta and 
oxidative stress. A summary of the neurodegenerative processes in AD brain due 
to Abeta associated oxidative stress is represented in Figure 4. 
 
 
1.4  Altered cellular responses: relevance in Alzheimer´s Disease 
 
Cellular stress due to oxidative damage or other stress factors, can promote 
two fundamental cellular responses: apoptosis (a precisely regulated form of cell 
death) and heat shock protein induction (which functions to protect cells and to 
mediate an accelerated recovery following damage). The balance between 
these two opposing pathways determines whether the cell lives or dies. 
 
1.4.1  Evidence for apoptosis in Alzheimer´s Disease 
 
Several studies suggest that neuronal death in AD is mediated by 
unregulated apoptosis. Apoptosis, or programmed cell death (PCD), is a highly 
conserved energy–requiring program for non-inflammatory cell death that is 
important in both normal physiology and disease. This extremely well organized 
process involves DNA fragmentation, membrane blebbing, cell shrinkage and 
disassembly into membrane-enclosed vesicles. These are eliminated by 
phagocytosis, therefore preventing an inflammatory response to the intracellular 
components (Grütter, 2000). 
Neuropathological studies have shown higher fragmentation of nuclear 
DNA in neurons, oligodendrocytes, astrocytes and microglia in brains of patients 
with AD than in age-matched controls (Su et al., 1994; Dragunow et al., 1995; 
Troncoso et al., 1996). These studies have been interpreted as evidence of 
neuronal loss in AD due to apoptosis, and that this may be initiated by the toxic 
Abeta peptide or other inducers of oxidative stress.  
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Oxidative stress, induced by Abeta or other factors, can trigger apoptosis 
associated events, activating caspases or increasing expression of apoptotic 
related proteins. Indeed, ROS induced damage present in AD brains has a 
dramatic effect on DNA (Lyras et al., 1997) and RNA (Nunomura et al., 2001). 
Several enzymes involved in DNA repair are dysregulated under oxidative stress 
conditions affecting the equilibrium of the DNA repair process which can lead to 
apoptosis. 
The poly (ADP-ribose) polymerase (PARP ?  a 113-KDa protein) is a DNA 
repair protein that is activated in response to DNA damage induced by oxidative 
stress. Single-stranded and double-stranded DNA breaks activate PARP which 
catalyzes the poly(ADP-ribosyl)ation of this damaged DNA using NAD+. 
Nevertheless, overactivation of PARP can result in cell death by necrosis, with a 
severe ATP depletion and massive consumption of the cofactor NAD+. 
Under oxidative stress conditions PARP is proteolytically cleaved by 
caspase-3 (an executor of apoptosis) yielding 89- and 24-KDa fragments (Tewari 
et al., 1995). Such cleavage essentially inactivates the enzyme by destroying its 
ability to respond to DNA strand breaks, and prevents depletion of NAD and ATP, 
which are thought to be required for latter events in apoptosis. Indeed, PARP 
cleavage prevents induction of necrosis during apoptosis and ensures 
appropriate execution of PCD mediated by caspases (Herceg and Wang, 1999). 
PARP cleavage by caspases is a hallmark of apoptosis. 
Besides oxidative stress, Abeta itself appears to also lead to apoptosis 
(Mattson et al ., 1998; Carter and Lippa, 2001; Kienlen-Campard et al., 2002). 
Indeed it is believed that the synapse loss and neuronal cell death characteristic 
of AD (and apoptotic processes) result largely from the neurotoxic effects of 
Abeta production. Moreover, treatment of rat cortical neurons showed that 
Abeta 25-35 (the neurotoxic fragment of Abeta peptide) induces increased 
caspase-3 activity and cleavage of PARP. In the presence of specific caspase 
inhibitors, Abeta induced PARP cleavage was prevented, but cell death still 
occurred. This suggests that activation of caspase-3 and other caspase(s) leads to 
different mechanisms of Abeta induced apoptosis (Harada and Sugimoto, 1999).  
In fact, experiments performed with Abeta 25-35 also showed that this active 
fragment of Abeta, through NO and probably other free radicals, induces 
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activation of PARP (Harada and Sugimoto, 1999; Strosznadjer et al., 2000). Hence, 
it is not surprising that Kienlen-Campard et al. (2002) demonstrated that neurons 
undergo apoptosis as soon as they accumulate intracellular Abeta following long 
term expression of human APP. Concordantly, it has been demonstrated that 
Abeta 1-42 is toxic to human neurons through activation of p53 and Bax 
proapoptotic pathway (Aurelio et al., 2000; Zhang et al., 2002). 
Furthermore, it has been shown that APP processing and Abeta formation 
were enhanced during neuronal apoptosis (LeBlanc, 1995; Galli et al., 1998). Also, 
the finding that the preselinins and APP proteins are substrates for different 
caspases enhances the possibility that dysregulation of PCD could be involved in 
the pathogenesis of the disease (Kim et al., 1997; Loetscher et al ., 1997; Pellegrini 
et al., 1999; Leutz et al., 2002). 
Although apoptosis is a fast event and AD is a slow neurodegenerative 
process, the presented data suggest a link between apoptotic pathways and 
neurodegeneration in AD. The mechanisms causing cell death may be 
overlapping with integrated events among the components interacting and 
contributing to a final pathway for neuron death in the disorder. Apoptosis may 
not be the leading cause of AD but it can occur as a consequence of it. 
 
1.4.2.  Heat shock proteins in Alzheimer´s Disease neuropathology 
 
Heat shock proteins (HSPs) act as molecular chaperones, which are 
ubiquitous, highly conserved proteins that play pivotal roles in living organisms. At 
the molecular level, chaperones protect against aggregation, solubilize protein 
aggregates, assist in the proper folding/refolding of various cellular proteins and 
target ultimately damaged proteins to degradation (SOti and Csermely, 2000). 
Chaperones are vital for our cells during their whole lifetime. However, they are 
needed even more after stress stimuli that induce protein damage. Stress leads to 
the expression of most chaperones, which therefore are called heat shock or stress 
proteins. These proteins are induced in living cells, playing a protective role and 
promoting their recovery following damage. In early stages of AD, a cerebral 
decrease in energy metabolism, along with a loss of functionally important amino 
acids, dysregulation of calcium homeostasis and increasing oxidative stress are 
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assumed to be stress related abnormalities capable of inducing heat shock 
proteins. 
HSPs have been reported to regulate the apoptotic pathway and also play 
a critical role in protein conformational diseases, such as AD (Carrell and Lomas, 
1997; Soto, 1999). In AD a change into beta-sheet conformation of Abeta peptide 
leads to fibrils assembly and a concomitant toxic effect towards neurons in vitro 
(Lorenzo and Yankner, 1994). HSP70, small HSPs (HSP27 and alpha crystalline B) 
and HSP40 have been reported to diminish amyloid fibril formation and 
subsequent toxicity (Shinohara et al ., 1993; Renkawek et al ., 1994; Muchowski et 
al., 2000).  
Many studies showed that several chaperone proteins, such as HSP70 are 
aberrantly expressed in AD brains (Yoo et al., 2001). Similarly, there is evidence for 
increased HSP70 expression in brains from patients with Down´s Syndrome (Yoo et 
al., 1999). Moreover, expression of these proteins appears to be related to 
overexpression of APP. In fact, the APP gene promoter contains a heat shock 
element and altered APP expression, induced by heat shock leads to increased 
accumulation of Abeta (Johnson et al., 1993). Accordingly Abe et al . (1991), using 
cultured lymphoblastoid cells suggested that APP mRNA was induced by heat 
shock treatment after the induction of HSP70 mRNA. HSP70-induced APP mRNA 
suggests a role of heat shock response in the induction of APP expression (Yoo et 
al., 2001). Furthermore, recent studies confirmed that HSP70, HSP90 and HSP32 play 
a neuroprotective role facilitating Abeta phagocytosis and clearance and 
cytokine production by activation of microglia (Kakimura et al., 2002). 
HSP70, HSP90 and HSP27 can regulate the activities and expression, or both, 
of apoptotic signalling molecules (Beere, 2001). Indeed, down-regulation or 
disruption of HSP70 expression results in apoptosis. Mosser et al. (1997) 
demonstrated that this chaperone is able to block apoptosis by inhibiting the 
apoptotic stress-activated protein kinase SAPK/JNK (c-jun N-terminal kinase) 
pathway. Clearly the HSP70 family has a crictical contribution to neuronal cell 
death and hence a strong association with AD. 
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1.5  Diagnosis for Alzheimer´s Disease 
 
Alzheimer´s Disease is the most common dementia among the elderly, 
appearing as a new “epidemic” threat to human civilization in the next century. 
As lifetime expectancy is increasing, the incidence of AD is expected to rise in the 
near future. Social and economic consequences of this disease will reach 
immense dimensions. To date, there are no available biological markers and an 
AD diagnostic is presently based on cognitive testing. There is no assay of 
objective ante mortem biochemical criteria to reveal the pathophysiology of this 
disease. Although other diagnostic tests such as routine blood examinations, brain 
imaging techniques, and neuropsychological tests, are used to exclude other 
disorders. Confirmation of AD is only obtained using post-mortem brain tissue. 
Hence, the development of a test, which is non-invasive, simple, cheap, using 
easily accessible body fluids, is urgently needed for AD diagnosis. Of note is that 
since AD is a multifactorial disorder, the use of a single marker is unlikely to be of 
value. Therefore the use of a combination of markers allows for a more accurate 
diagnosis.  
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Even though it is not clear how neurons die and synapses are lost in AD, 
present evidence indicates that APP processing, oxidative stress and Abeta 
toxicity are the most important mechanisms to explain the development of AD. 
This work aimed to adress the effect of oxidative stress on APP processing. 
Further, given that APP appears to belong to the RIP proteins, phosphorylation 
dependent events take on added significance. Thus, the first specific objectives 
were as follows: 
1. To study the effect of oxidative stress on APP processing 
2. Monitor phorbol ester induction of APP processing under oxidative stress 
conditions 
 
Although abnormal alterations in protein expression levels (such as HSP in 
AD brains) have been well document, the link to pathology is elusive. As such, 
there is a need to develop an experimental model system to study potentially 
relevant molecular relationships, to correlate molecular markers to AD and this 
may contribute to the development of novel diagnostic tools. Therefore, and after 
having established that oxidative stress did in fact play a significant role on APP 
processing, we went to analyze how oxidative stress and other cellular stresses 
affected protein expression levels. Our focus was on the long term effect of these 
exposures, being that AD is a progressive neurodegenerative disorder. The long 
term goal of this work addresses the monotorization of molecular markers as a 
useful tool for the early diagnosis of AD. Hence the specific objectives for this 
section were: 
3.  To characterize altered protein expression in response to stress agents 
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A list of all reagents and the equipment used is presented in Chapter 7 
(ANNEXES). All reagents were cell culture grade or ultrapure. 
 
 
3.1  Cell culture 
 
Two cell lines were used: non–neuronal COS-1 cells and neuronal-like PC12 
cells. COS-1 cells were grown in DMEM supplemented with 10% heat inactivated 
foetal bovine serum, 1% antimycotic-antibiotic solution and 3.7 g/l NaHCO3. PC12 
cells were cultured in RPMI medium supplemented with 10% heat inactivated 
horse serum, 5% heat inactivated fetal bovine serum, 1% antimycotic-antibiotic 
mix and 0.85 g/l NaHCO3. Cultures were grown and routinely passaged into tissue 
culture dishes. Cells were observed with an inverted optical microscope. Before 
replating, COS-1 cells were dissociated with trypsin. Cell cultures were maintained 
at 37ºC and 5% CO2. For experimental procedures COS-1 and PC12 cells were 
plated on 6-well plates after conting with a hemacytometer. PC12 cells were 
plated onto poly-L-ornithine (100 ?g/ml). Multiwells were pre-treated for 5 min with 
poly-L-ornithine, and then washed twice with dH20 prior to use. 
 
 
3.2  Experimental models 
 
    3.2.1  Oxidative stress model to study APP processing  
 
Sodium azide was used to induce oxidative stress by inhibiting cytochrome 
c oxidase activity. Experiments were performed in the presence of 2DG which 
substitutes glucose in the incubation medium and is not metabolized by the cells. 
Confluent monolayers of cells were plated as described on section 3.1 and 
then washed twice with PBS before undergoing different treatments. Cells were 
treated with various concentrations (0.01-10 mM) of sodium azide (NaN3) in the 
presence or absence of 2DG in serum-free, glucose-free and pyruvate-free 
medium for 2 hr at 37ºC. Cell viability was assessed following treatments with 
sodium azide by the MTT reduction assay (see section 3.3). 
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    3.2.2  Stimulation of APP processing with phorbol esters 
 
PC12 and COS1 cells of approximately 90% confluence were used. For the 
phosphorylation dependent response, experiments were performed by co-
incubating 50 mM 2-deoxyglucose (2DG), 1 or 10 mM sodium azide (NaN3) and 0,5 
?M phorbol 12-myristate 13-acetate (PMA), which is a PKC activator, or 1 ?M OA 
(phosphatase inhibitor), for the same period of time in medium free of  serum, 
glucose and pyruvate. 
 
    3.2.3  Stress conditions tested for alterations in protein expression 
 
3.2.3.1  Exposure to sodium azide  
 
Having established that oxidative stress did in fact play a significant role on 
APP processing, we went to study the long term effect of sodium azide on protein 
expression. These experiments were carried out by incubating the cells at 
approximately 80% confluence, with 10 mM sodium azide in serum-free medium 
for 2hr and allowed to recover during an 18 hr and a 24 hr period. 
 
3.2.3.2  Heat shock 
 
Heat shock experiments were used to induce HSPs (like HSP70). Cells 80% 
confluents were heat shocked during one and a half hours at 44ºC and allowed 
to recover in serum-free medium for 18 and 24 hrs. 
 
3.2.3.3  Exposure to Abeta  
 
Abeta 1-40 and Abeta 25-35 were prepared as 1 mM stock solutions in 
dH2O. 80% confluent PC12 and COS1 cells were exposed to 10 and 20 ?M Abeta 
1-40 or Abeta 25-35 in serum-free medium during 24 hr. 
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3.3  Measurement of cell viability 
 
Cell viability was determined using the MTT assay. This method is based on 
reduction by mitochondria of MTT (a water soluble tetrazolium salt) to formazan, 
an insoluble intracellular purple product. The extent of reduction of MTT was 
measured spectrophotometrically at 570 nm, according to Mossman (1983). 
Briefly, after treatment of the cells, the medium was removed and MTT 
solution (0.5 mg/ml of serum-free DMEM) was added and incubated for 3hr at 
37ºC. Resulting insoluble formazan precipitates were solubilized with acidic 
isopropanol. Absorbance of converted dye was measured at 570 nm. The viability 
of the cells was expressed as a percentage of control cells. 
 
 
3.4  Sample collection and immunodetection 
 
After the appropriate treatments, media and cells were collected into 1% 
SDS and boiled during 10 min. Cell lysates were sonicated during 30 seconds and 
samples stored at -20C. Protein determination was performed using a BCA assay 
(see section 3.4.1) and normalized protein samples were electrophoretically 
separated by SDS-PAGE (see section 3.4.2). Separated proteins were transferred 
onto a nitrocellulose membrane (see section 3.4.3) followed by immunoblotting for 
the specific proteins (see section 3.4.3.2). Detection was carried out using a 
chemiluminescent method (see section 3.4.3.2.1) or a colorimetric method (see 
section 3.4.3.2.2). The resulting bands were quantified by densitometry (see 
section 3.5). 
 
    3.4.1  Protein content determination 
 
For protein quantification of cells lysates the BCA assay, based on the use 
bicinchonic acid (BCA) for the colorimetric detection and quantification of total 
protein (Smith et al., 1985), was used. This test is based on the capability of proteins 
to reduce Cu2+ to Cu+ in an alkaline environment. BCA produces a purple colour 
in the presence of the reduced Cu+ ion. The soluble complexes exhibit a strong 
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absorbance that can be read at 562nm. The quantitative assays were performed 
according to the manufacturers instructions and bovine serum albumin (BSA) was 
used as standard. 
Briefly, the quantitative analyses were carried out using 50 ? l of the 
collected cell lysates (see section 3.4). Known concentrations of the BSA were 
used as standards and final volumes of 50 ? l were adjusted with 10% SDS and 
water. Both samples and standards were incubated with 1 ml of working reagent, 
which is prepared with 50 parts of reagent A to 1 part of the reagent B. All samples 
were incubated at 37ºC during 30 minutes and then read at 562 nm. 
 
    3.4.2  SDS-Polyacrylamide gel electrophoresis  
 
 SDS – Polyacrylamide gel electrophoresis (SDS-PAGE) is an analytical 
technique of electrophoresis of proteins on polyacrylamide gels under conditions 
that ensure dissociation and characterization of proteins and peptides in mixtures. 
The anionic detergent SDS is used in combination with a reducing agent 
(mercaptoethanol) and heat to dissociate proteins before they are loaded on the 
gel. SDS-PAGE was carried out using a discontinuous buffer system, described by 
Laemmli (1970), in which a non-restrictive large-pore gel called a stacking gel is 
layered on top of a resolving gel. In this system each gel layer is of different pH 
and ionic strength, and the buffer in the reservoirs (running buffer) is different from 
the gel buffers.  
SDS-PAGE was performed using a Hoefer electrophoresis system. The 
optimum acrylamide concentration of the resolving gel was selected according 
to the molecular weight of the proteins being monitored (Table 1). The gel was 
prepared and allowed to polymerize at room temperature. Subsequently, the 
3.5% stacking gel solution was prepared and loaded on top of the resolving gel. A 
Teflon comb was inserted and the gel was left to polymerize at room temperature. 
Prior to loading, the samples were boiled in SDS gel loading buffer for 3 minutes to 
ensure protein denaturation. Commercial standards of known molecular weight 
proteins were used as markers. Proteins were separated electrophoretically (90 
mA) for 3-4hr. The amount of total protein loaded varied depending on the 
protein to be detected (Table 1). 
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Table 1. Percentage of acrylamide gels used and the corresponding amount of total protein 
loaded for each. 
 
Protein MW (KDa) Acrylamide gel ? g protein
APP/sAPP
ranging from 
130-110
7.5% 45/100
PARP 89 8% 70
HSP70 70 10% 35
Tubulin 50
___
35
PP1 37 12% 35
 
 
 
    3.4.3  Western blotting 
 
Western blotting is a technique where electrophoretically separated 
components are transferred from a gel to a solid support. In this work, proteins 
were electrophoretic transferred to a nitrocellulose membrane (Protan, Schleicher 
& Schuell) (Burnette 1981). After transfer the proteins were detected using specific 
antibodies (section 3.4.3.2). 
 
3.4.3.1  Transfer of proteins from the membrane to a solid support 
 
Briefly, the gel was placed in contact with nitrocellulose filter, which were 
then sandwiched between Whatman 3MM paper, two porous pads, and two 
plastic supports. The sandwich was immersed in an electrophoresis tank, equipped 
with standard platinum electrodes, containing transfer buffer. The nitrocellulose 
filter was placed toward the anode. An electric current of 200mA was applied for 
about 15 hrs; during this time, the proteins (charged negatively by SDS) migrate 
from the gel toward the anode and become attached to the nitrocellulose filter. 
After the transfer of the proteins, the membrane was removed from the sandwich 
and allowed to dry at room temperature. 
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 3.4.3.2  Immunological detection of the immobilized proteins 
 
Transferred proteins were probed with specific antibodies. Non-specific 
binding was reduced by blocking with non-fat dried milk (Jonhson et al., 1984). 
The procedure used was to wet the membranes in TBS solution for 2-3 minutes, 
proceeded by incubation of the membranes in the blocking solution during 2 hrs. 
Subsequently, membranes were incubated with an unlabeled primary antibody 
direct against the target protein, for 2-4 hrs (depending on the primary antibody 
used). The primary antibody was removed and the filters washed three times (10 
minutes) with TBS-T. The membranes were then incubated with a secondary 
antibody (for 1h30 min), coupled either with horseradish peroxidase or with 
alkaline phosphatase (enzyme-labelled antibodies). After further washing, the 
antigen-antibody-antibody complexes on the nitrocellulose filter were detected 
by autoradiography or in situ enzymatic reactions depending on the protein being 
analyzed (Table 2). 
 
3.4.3.2.1  Chemiluminescent protein detection 
 
ECL or ECL plus are chemiluminescent detection reagents. The ECL 
(enhanced chemiluminescence) reaction is based on the oxidation of the cyclic 
diacylhydrazide luminal (Whitehead et al., 1979) and ECL Plus utilizes a technology 
based on the enzymatic generation of an acridinium ester, which produces a 
more sensitive light emission of longer duration than ECL. 
 After incubation with secondary antibody (horseradish peroxidase 
labelled), the membranes were washed and then incubated with the working 
mixture of the chemiluminescent detection reagent. The incubation occurred 
during 1 min for ECL or 5 min for ECL plus at room temperature in a dark room. The 
membranes were wrapped in SaranWrap and exposed to autoradiography films 
(Kodak) in an X-ray film cassette. Films were developed and fixed with 
appropriate solutions (Kodak). 
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3.4.3.2.2  Colorimetric protein detection  
 
 The substrate NBT/BCIP is converted in situ into an intense black purple 
precipitate at the site of enzyme binding (alkaline phosphatase). The substrate 
solution is stable in the absence of enzyme. The reaction proceeds at a steady 
rate, thus allowing accurate control of the development of the reaction. 
Basically, after incubating the membranes with secondary antibody 
conjugated with alkaline phosphatase, the membranes were washed and 
incubated with substrate solution. The blot was developed at room temperature 
with agitation until the bands were suitably dark (5-30 minutes). The reaction was 
stopped with stop solution. The membranes were washed with dH20 and dried for 
further analysis. 
 
Table 2. Protein  antibodies  and detection method used. 
 
Protein First antibody Secondary antibody Detection method
APP 22C11 Peroxidase labelled anti-mouse ECL
sAPP 22C11 Peroxidase labelled anti-mouse ECL Plus
PARP Anti-PARP Peroxidase labelled anti-rabbit ECL PLus
PP1 Anti-PP1 Peroxidase labelled anti-rabbit ECL
HSP70 Anti-HSP70
Monoclonal anti-rabbit alkaline
phosphatase conjugate
NBT/BCIP
Tubulin Anti-beta-tubulin
Anti-mouse alkaline phosphatase
conjugate 
NBT/BCIP
 
 
 
3.5  Statistical analysis 
 
Quantitative analyses were performed using densitometric scanning using a 
BioRad system. Data were expressed as means ±SE of triplicate determinations, 
from at least three independent experiments. 
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4.1  The effect of oxidative stress on APP processing 
 
Experiments were carried out as described in section 3.1, in the presence of 
sodium azide (3.2.1), and the effect short term incubation on cell viability was 
evaluated (3.3). 
 
4.1.1  Effect of sodium azide on cell viability 
 
PC12 and COS-1 cells at 90% confluency were treated with increasing 
concentrations of sodium azide, in the presence of 50 mM 2DG, and cell viability 
was determinated. The results obtained are shown in Figure 5. For both cell lines 
tested, sodium azide decreased cell viability, with a more pronounced effect at 
10 mM concentration. Under these stress conditions, PC12 cells appear to be more 
sensitive, being that their viability decreased approximately 50%, whereas COS-1 
cells are affected much less (approximately 80% viability). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Cell viability was measured using MTT reduction test. Graph A shows the cell viability for 
PC12 cells and graph B for COS-1 cells. 
 
Given the results obtained, in particular the drastic effect of 100 mM Na N3 
on PC12 cell viability, subsequent experimentation excluded NaN3 concentrations 
above 10 mM. 
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4.1.2  Effect of sodium azide on sAPP production 
 
Oxidative stress was induced using sodium azide, as described above, and 
cell media and cell lysates were analyzed by immunoblotting (3.4.3) for both cell 
lines. Figure 6 shows the results of the western blots. Tubulin was used as a control 
(Figure 6, I) showing no alterations throughout the experiments. Analysis of the 
medium (Figure 6, III and IV) revealed that for both PC12 and COS-1 cell lines sAPP 
production decreased upon addition of sodium azide, and overall there was a 
corresponding decrease in intracellular mature APP (Figure 6, II).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Effect of NaN3 treatment on PC12 and COS-1 cells. Cells were incubated at 37ºC for 2 hours 
with different concentrations of NaN3 in the presence of serum free DMEM and 50 mM 2DG. Cell 
media and lysates were collected and analyzed by western blot. I. Control blot s for beta-tubulin. II 
Western blot s of cellular lysates probed with 22C11 for HoloAPP. The different bands corresponding to 
the mature and immature isoforms of APP can be clearly identified: a)  immature APP695, b) 
immature APP751/770, c) mature APP695 and, d)  mature APP751/770. III. sAPP secreted into cell medium. 
IV. Quantification of sAPP secreted (mean ±  SEM).  
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It was noticeable, however that with 10mM NaN3 the concentration of 
intracellular APP increased in PC12 cells, possibly due to the lack of processing 
under toxic conditions. This was particularly observed for the APP751/770 isoforms. By 
contrast the immature APP695 isoform appears to remain relatively unaffected. 
Furthermore, in COS-1 cells the migration pattern of the different APP isoforms is 
altered immediately upon addition of 2DG, presumably by interfering with APP 
maturation. This effect was reversed with increasing sodium azide concentrations. 
Quantification of the results revealed that COS-1 cells appear to be more sensitive 
to the addition of NaN3 in relation to sAPP production.  
 
 
4.2  Phorphol ester stimulation of APP processing under oxidative stress 
condtions 
 
Having established that sAPP production decreased in both cell lines used, 
it was tested whether the phosphorylation dependent sAPP increase (section 
1.2.1) could still be obtained under stress conditions. Western blot analysis of cell 
lysates and media of cells exposed to PMA and OA revealed that the rate of sAPP 
production can be increased 3-4 fold upon addition of PMA and 2 fold upon 
addition of OA (Figure 7). This is true for COS-1 cells and to a lesser extent PC12 
cells. However, upon being subjected to the experimental stress conditions, there 
is a different response for PMA and OA. In the presence of 1 mM NaN3 the PMA 
effect is diminished and the OA effect on sAPP is abolished. However, in the 
presence of 10 mM NaN3 both the PMA and OA effects are completely abolished. 
For COS-1 cells the situation is further complicated, as the mere addition of 2DG 
appears to abolish the OA induction of sAPP secretion. 
 
 
 
 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Effect of OA and PMA on PC12 and COS-1 cells treated with NaN3. Cells were incubated at 
37ºC for 2 hours with different concentrations of NaN3 in serum free DMEM, 50 mM 2DG and 0.5 ? M 
PMA or 1 ? M OA. Cell media and lysates were collected and analyzed by Western blot. I. HoloAPP 
isoforms probed with 22C11. The different bands corresponding to the mature and immature APP 
isoforms are identified as follows: a)  immature APP695, b) immature APP751/770, c) mature APP695 and, 
d)  mature APP751/770. II. sAPP secreted into cell medium. III. Quantification of sAPP secreted. IV. Fold 
increase over basal. 
 
 
 
A. PC12  B. COS-1  
III. sAPP quantification 
      2DG (50mM)        ?                      +                   +                    +                     
      NaN3 (mM)           0                     0       1                   10            
         
    2DG (50mM)        ?                      +                     +                     +                     
    NaN3 (mM)           0                     0       1                    10            
         
0
20
40
60
80
100
C  OA P M A
0
20
40
60
80
100
C OA P M A
IV. Fold increase over basal 
      2DG (50mM)     ?                       +                    +                    +                     
      NaN3 (mM)        0                      0                    1                   10  
      2DG (50mM)       ?                        +                    +                       + 
      NaN3 (mM)          0                       0                    1                      10            
0
1
2
3
 OA PMA
0
1
2
3
4
5
6
7
OA P M A
I. HoloAPP 
Marker (~KDa) 
b 
a 
d 
c 127 
200 
c 
d 
a 
b 
II. sAPP 
2DG (50mM)            ?                   +                   +                   +                     
NaN3 (mM)               0                  0                   1                  10            
PMA (0.5? M)      ?      ?      +     ?     ?      +     ?      ?      +     ?      ?      + 
OA (1? M)          ?       +     ?      ?     +     ?      ?      +     ?      ?      +     ?  
 
2DG (50mM)          ?                     +                  +                    +                     
NaN3 (mM)             0                    0                   1                   10            
PMA (0.5? M)   ?      ?      +     ?       ?     +     ?      ?      +     ?       ?     + 
OA (1? M)         ?     +     ?       ?      +    ?       ?      +     ?     ?       +     ?  
127 
Marker (~KDa) 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
45 
Analysis of the corresponding cellular lysates (Figure 7) reveals that, as 
previously shown, increased sAPP production due to PMA or OA addition, causes 
a decrease in intracellular mature APP. However, at increased NaN3 
concentrations, there is an increase in the intracellular levels of APP, leading us to 
deduce that APP processing appears to be blocked since it remains unaffected 
even after the addition of PMA (Figure 7, I). It appears that may be a non-specific 
toxic effect that is being exerted on the cells under these extreme stress 
conditions. This also results in diminished sAPP production. 
 
 
4.3 Alterations in protein expression under cellular stress conditions 
 
Having tested the short term effect of sodium azide on APP processing, we 
went to study the long term effect on the expression of APP and other proteins. 
Other cellular stresses relevant to AD were included and their effects on the same 
proteins were studied. Namely we monitored protein expression levels and 
induction of apoptosis as detected by PARP cleavage. 
 
4.3.1  Exposure to sodium azide 
 
During the course of these experiments PC12 and COS-1 cells were 
incubated with 10mM NaN3 and allowed to recover for 18 and 24 hrs. 
Methodology used was as outlined in section 3.2.3.1. 
The cell lysates were tested for the presence of various proteins by 
immunoblotting 3.4.3, and also for apoptosis as determined by PARP cleavage 
products. For both cells lines a decrease in APP expression, in particularly for the 
751/770 APP isoforms was detected (Figure 8, I ). APP695 appears to be less sensitive 
to exposure to sodium azide stress than the other isoforms. Likewise PP1 expression 
also decreased in PC12 cells but was almost unaffected in COS-1 cells (Figure 8, 
II). Similarly HSP70 expression was unaffected in COS-1 cells but decreased in the 
PC12 cell line. Moreover, apoptosis seems to have occurred as detected by PARP 
cleavage products (Figure 8, IV). Together, these results indicate that the 
neuronal-like PC12 cell line appears to be more sensitive to long term exposure to 
sodium azide than the non-neuronal COS-1 cells. 
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Figure 8. Long term effect of sodium azide on protein expression. PC12 (column A) and COS-1 
(column B) cells were treated with 10 mM sodium azide during 2hr in serum-free medium and 
allowed to recover during 18 and 24 hr. The effect  on HoloAPP isoform expression, PP1, HSP70 and 
PARP cleavage were also analyzed. The different bands corresponding to the mature and immature 
APP isoforms are identified as follows: a)  immature APP695, b) immature APP751/770, c) mature APP695 
and, d)  mature APP751/770.  
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4.3.2  Heat shock 
 
PC12 and COS-1 cells at 80% confluence were heat shocked and allowed 
to recover during 18 and 24hrs. Procedure was as described on section 3.2.3.2. The 
results obtained are shown on Figure 9. For both cell lines tested heat shock 
induced expression of HSP70 as expected (Figure 9, III.). Contrastingly, a decrease 
in APP expression was observed with heat shock, and it seems that the isoforms 
751/770 were again more sensitive than isoform 695 (Figure 9, I.). Also, apparent 
was a decrease in PP1 expression for both cell lines (Figure 9, II.) and an increase 
of PARP cleavage under these stress conditions for COS-1 cells (Figure 9, IV.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Heat shock effect on protein expression. PC12 (column A) and COS-1 (column B) cells were 
heat shocked during one hours and a half at 44ºC. Cells were then allowed to recover during 18 and 
24 hrs in serum free medium. Cells lysates were collected and analyzed. I. HoloAPP isoforms probed 
with 22C11. The different bands corresponding to the mature and immature APP isoforms are 
identified as follows: a)  immature APP695, b) immature APP751/770, c) mature APP695 and, d)  mature 
APP751/770. II. PP1 expression III. HSP70 expression. IV. 85 KDa PARP cleaved fragment. 
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4.3.3  Exposure to Abeta  
 
 PC12 and COS-1 cell were treated with Abeta 25-35 or 1-40 peptides, as 
mentioned in section 3.2.3.3, and the effects on protein expression were 
evaluated, (Figures 10 and 11). For both cell lines incubation with Abeta 25-35 
leads to increased expression of mature APP695 and immature APP751/770 isoforms 
(Figure 10, I), whereas Abeta 1-40 had no effect on APP expression levels at the 
concentrations tested (Figure 11, I ).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Abeta 25-35 effect on protein expression. PC12 (column A) and COS-1 (column B) cells 
were treated with 10 ? M and 20 ? M Abeta 25-35 during 24hr in serum free medium. Its effect on 
Tubulin (I), HoloAPP isoforms (II), PP1 (III), HSP70 (IV) and PARP cleavage (V) were analyzed. The 
different bands corresponding to the mature and immature APP isoforms are identified as follows: a)  
immature APP695, b) immature APP751/770, c) mature APP695 and, d)  mature APP751/770.  
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Figure 11. Abeta 1-40 effect on protein expression. PC12 (graph A) and COS-1 (graph B) cells were 
treated with 10 ? M and 20 ? M Abeta 1-40 during 24hr in serum free medium. Cells lysates were 
collected and analyzed. I. Control blot t o tubulin. I I. HoloAPP isoforms probed with 22C11. The different 
bands corresponding to the mature and immature APP isoforms are identified as follows: a)  
immature APP695, b) immature APP751/770, c) mature APP695 and, d)  mature APP751/770. PP1?(III), HSP70 
(IV) and PARP cleavage (V). 
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From a molecular point of view other aspects were the same for both cell 
lines tested. PP1 expression decreased only marginally (Figure 10 and 11). HSP70 
expression on the other hand remained unaltered for both cell lines, and this may 
indicate that these experimental conditions were less stressful for cells than the 
experiments with sodium azide. The PARP immunoblot revealed increased 
cleavage with both peptides tested, although less so for Abeta 1-40 (Figure 10, V. 
and Figure 11, V). Tubulin, used as a control marker showed no alterations under 
conditions of stress. Overall, under these stress conditions, Abeta 1-40 appears to 
induce fewer molecular alterations with respect to the markers tested (Figure 11), 
than Abeta 25-35 (Figure 10). 
 
Section 4 in its entirety reveals that when cell are subjected to stress, 
molecular alterations, either in protein processing or protein expression can be 
detected. 
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5. DISCUSSION & CONCLUSIONS 
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5.1 Short term effect of sodium azide on the processing of the Alzheimer’s 
amyloid precursor protein 
 
 APP is ubiquitously expressed. However, as discussed in the Introduction, 
Abeta deposition does not occur throughout the body of an AD patient. 
Additionally, several previous studies point to cell type dependent effects. Hence, 
throughout the course of this work two cell lines were compared: PC12 and COS-
1. PC12 cells are a rat pheochromocytoma-derived line and COS-1 cells are a 
monkey kidney cell line. In terms of cellular stress various aspects were addressed. 
First we addressed oxidative stress by adding NaN3 to the cells in culture, since it is 
routinely used to mimic oxidative stress (reviewed in Gibson, 2002).  
In order to evaluate the overall toxic effect of sodium azide on PC12 and 
COS-1 cells, cell viability was monitored. Such experiments are important since 
they indicate whether cells are still under near physiological conditions, or if they 
are entering cell death due to grossly non-physiological conditions. Cell death is 
itself an interesting phenomenon given that neuronal degeneration is involved in 
AD and, if oxidative stress induces cell toxicity and apoptosis, there is 
circumstantial evidence linking these cellular phenomena to the disease 
condition.  
The cell viability results indicated that PC12 cells are relatively more sensitive 
to sodium azide than COS-1 cells (Figure 5). In both cases, cell viability only started 
to be significantly affected at sodium azide concentrations in excess of 10mM. 
Moreover, and as previously identified by Gasparini et al. (1997), oxidative stress, 
as induced by NaN3, affects APP metabolism resulting in a decrease in sAPP 
production in both cells lines (Figure 6, III ). However, this decrease is more evident 
in COS-1. In fact, for COS-1 cells sAPP production falls to less than 50% when 
compared to the control, whereas for PC12 cells the sAPP production falls to 
approximately 60% of control. Interestingly, COS-1 cells were more resistant, in 
terms of cell viability, to the addition of sodium azide. Hence, COS-1 cells are more 
resistant to the addition of NaN3 but show greater sensitivity in terms of sAPP 
production. PC12 cells, on the other hand, are more sensitive to sodium azide 
addition but do not show such a sharp decrease in sAPP production upon 
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addition of NaN3. Hence, both cell lines tested respond differently to sodium azide 
in terms of cell viability and sAPP production. 
Interestingly, the decrease in sAPP secretion into the medium is also 
accompanied by a decrease in intracellular mature APP. The latter is contrary to 
what would be expected from a simple APP processing perspective. That is, if 
sAPP production decreases, one would expect mature APP to accumulate in the 
cell. Thus, the results imply that, under these experimental conditions, the supply of 
mature APP is a limiting factor to sAPP secretion, and it would appear that APP 
maturation is also being affected. 
The intracellular levels of APP were observed to fluctuate considerably 
during the course of these experiments. Under the most extreme stress conditions 
tested (10 mM sodium azide), intracellular APP appears to be significantly 
increased (particularly APP751/770) and sAPP production is further decrease. Again, 
this observation runs contrary to the ‘a priori’ expected correlation. One would 
expect that a higher concentration of intracellular APP might result in increased 
processing and accordingly yield increased sAPP production. Therefore, the 
observed decrease in sAPP production is likely to reflect the oxidative stress 
induced by sodium azide. 
Of particular note in COS-1 cells, a shift in APP isoform mobility on SDS-PAGE 
could be detected in the presence of 2DG (Figure 6, II). These results suggest that 
the observed experimental alterations in APP metabolism may not result from 
mitochondrial dysfunction, as postulated by other authors, but are probably 
related to effects induced by the use of the 2DG glucose analogue. It probably 
exerts additional effects, as detected by altered mobility of HoloAPP. In particular, 
there is an apparent mobility shift for the immature 751/770 isoforms in COS-1 cells. 
It appears, therefore, that for this cell line, these APP isoforms are selectively 
affected under the stress conditions tested. It has previously been postulated 
(McFarlane et al., 1999) that different glycoforms of the protein may exist, resulting 
in significant heterogeneity of the protein, which in turn has important 
consequences in its processing and function. This being the case, APP695 and 
APP751/770 could potentially be responding differently under similar cellular stress 
conditions. Whether this subsequently affects the availability of HoloAPP for 
processing remains to be elucidated. Nonetheless, identifying altered 
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glycosylation is potentially very interesting, as altered protein glycosylation has 
been associated with AD (McFarlane et al., 1999). Of further interest is the 
suggestion that differential glycosylation of cerebrospinal fluid 
acetylcholinesterase in AD may serve as a potential diagnostic marker for the 
disease. Furthermore, protein glycosylation state appears to be important in 
protein sorting and targeting to specific cell sites, such as the cell surface (Nguyen 
and Amera, 1996). However, it remains unclear how this altered glycosylation 
arises and whether oxidative stress could be a contributing factor. While changes 
in mobility for immature APP751/770 were apparent, this was not so for mature APP 
isoforms in COS-1 cells, although the amount of mature APP751/770 decreased 
dramatically (Figure 6, II). The APP isoforms in the PC12 cell line did not exhibit such 
a mobility shift in the presence of 2DG. Again bringing to the fore potential 
differences in APP metabolism between the non-neuronal and neuronal like cell 
lines. 
In all these experiments we used sodium azide, which is typically used as an 
inducer of oxidative stress, being an inhibitor of cytochrome c oxidase. Sodium 
azide provoked a decrease in sAPP production, and a decrease in intracellular 
mature APP. However, upon addition of 10mM NaN3, intracellular APP 
concentration appears to increase. Increased levels of APP expression have been 
associated with other stress conditions, such as incubation with Abeta 25-35 
(Figure 10, II) or addition of staurosporine (unpublished observations). Interestingly, 
higher concentrations of NaN3 in COS-1 cells reverts the effect of 2DG on APP 
isoform mobility. Taken together these results suggest that sodium azide is not a 
specific inducer of oxidative stress. It appears that our results also support the 
observation that sodium azide may be rather non-specific (Hedin and Fowler, 
2000). Nonetheless, NaN3 is clearly inducing cellular stress and affecting APP 
processing; as such it provides an interesting ‘in vitro’ model to study APP 
processing under conditions of stress. 
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5.2 Dissociation of APP processing pathways under conditions of cellular 
stress 
 
The effect of phosphorylation on APP metabolism and processing has been 
well documented and, as already discussed, several lines of evidence have 
suggested that oxidative stress is involved in Alzheimer Disease. Both altered 
phosphorylation and oxidative stress affect Abeta production, which is thought to 
be a key aspect in the pathology of AD. Additionally, given the potential role that 
APP may play as a signal transduction molecule, with consequences for signal 
transduction therapeutics (da Cruz e Silva et al ., 2003), we went on to study the 
effect of PMA and OA under the stress conditions tested (Figure 7). It is important 
to understand and characterize cellular responses to phorbol esters under stress 
conditions, as cells in AD patients are also highly likely to be under stress. Previous 
studies showing an increase in sAPP production in response to phorbol esters 
(Buxbaum et al., 1993; da Cruz e Silva et al ., 1993; da Cruz e Silva et al ., 1995a) 
implicate a concomitant decrease in Abeta, thus highlighting the potential 
interest of this observation for therapeutics. Hence, we set out to investigate 
whether phosphorylation dependent sAPP stimulation could still be detected 
under conditions of stress. Figure 7 (IV) shows that for PC12 cells the PMA response 
(2-fold increase in sAPP) still occurs at 1mM but not at 10 mM NaN3. The case is 
similar for COS-1 cells, although the stimulation is around 4-fold. The peak in the 
PMA response for COS-1 cells upon addition of 2DG reflects a lower basal level of 
sAPP, as described in the previous section. Consistent for both cell lines is the 
finding that at 10 mM sodium azide the PMA dependent sAPP increase is 
abolished. 
As already discussed, PMA-stimulation of sAPP production is important as it 
can potentially lead to decreased Abeta formation. Under these experimental 
conditions, where PMA-induced sAPP production is maintained, there is a strong 
indication that even under oxidative stress conditions PMA can still potentially 
reduce Abeta production. That is, the potentially therapeutically beneficial PMA 
effect is still observed under oxidative stress conditions. The response to OA 
however, and unexpectedly, is different. Typically, OA (like PMA) produces an 
increase in sAPP production. This response was abolished, in both cell lines tested, 
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when they were subjected to sodium azide induced stress (Figure 7, II). Thus, under 
stress conditions we can dissociate two phosphorylation sensitive events affecting 
sAPP production. One is sensitive to PMA and OA, and the other is only sensitive to 
PMA. Alterations in the biochemical responses under stress conditions may offer 
interesting clues to the molecular basis of AD and therapeutic approaches. 
 
 
5.3 Long term effect of exposure to sodium azide and heat shock 
 
 In the next stage of this project, and after establishing that sodium azide 
induced stress did in fact produce interesting short term effects on APP processing, 
we went on to evaluate how sodium azide and other cellular stresses relevant to 
AD affected the expression of various proteins. We chose to monitor proteins that 
appear to be relevant from an AD pathology perspective. PARP cleavage was 
also included in our molecular analysis, since apoptosis has been associated with 
AD. 
 Treatment of cells with NaN3 or heat exposure, followed by a recovery 
period produced various adverse effects, detectable after 18hr and 24hr. For 
COS-1 cells both insults appeared to induce apoptosis, as determined by the 
PARP immunoblot (Figure 8 and 9, IV). Likewise, both treatments produced a 
decrease in HoloAPP and PP1 in both cell lines. Of particular note is the finding that 
the APP751/770 isoforms appear to be particularly affected (for example Figure 8 (I) 
for COS-1 cells, where the disappearance of the above mentioned isoforms is 
virtually absolute). HSP70 induction did not differ significantly for the two types of 
stress being considered here. With heat shock a typical heat shock response was 
observed (Figure 9, III), HSP70 induction is obvious for both cell lines). However, 
HSP70 does not alter at all in COS-1 cells following NaN3 exposure and, by 
contrast, it decreases in PC12 when subjected to NaN3 (Figure 8, III). 
 Comparing the long term effect of exposure to sodium azide and heat 
shock, it would appear that heat shock is more aggressive in terms of altered 
expression of HSP70 and PP1. In terms of APP expression however, NaN3 appears to 
be more detrimental. Lastly, if one compares PC12 and COS-1 cells they appear 
to be similarly affected under the conditions tested. 
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5.4 Long term effect of exposure to Abeta 
 
Having established that NaN3 and heat stress can provoke a molecular 
response with relevance to AD, we went to test the effect of two pathologically 
relevant candidates, Abeta25-35 and Abeta1-40. The particular interest in these 
peptides is that they can be deposited in senile plaques. Both have been used 
extensively for this type of experimentation, particularly the latter. The results 
obtained for PP1, HSP70 and PARP (the latter only in COS-1 cells) revealed only 
small alterations of the proteins in the cellular lysates. This rather suggests that the 
cellular stress induced by Abeta is moderate by comparison to the other stresses 
tested. Of particular significance is the hitherto undescribed result that Abeta25-35 
considerably increases expression of APP itself. This is important on several levels: 
 
i. APP appears to be similar to RIP proteins. The latter 
produce peptides that can regulate their own 
expression. Since Abeta exposure can induce APP 
expression, this provides indirect evidence for APP as a 
RIP protein. 
ii. Potentially, excess Abeta produced in AD patient 
brains can induce increased expression of APP and 
increased Abeta production in a ‘positive feedback’ 
pathological mechanism. 
iii. Individuals with Down’s syndrome, having an extra 
copy of the APP gene, have early onset AD, exhibiting 
a direct correlation between dose effect and age of 
AD onset. 
iv. The fact that AD is a progressive disorder, correlates 
with Abeta inducing APP expression leading to further 
Abeta production in a time dependent manner. 
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Hence, it would appear that the pathological consequence of the 
appearance and deposition of the first Abeta peptides can be considerable. 
Indeed, a small amount of Abeta can have direct consequences and although 
Abeta addition appears to be less traumatic to the cell, compared to other 
stresses tested, it may in fact be more toxic to the cell due to a cumulative effect. 
 
 
5.5 Potential application of molecular markers 
 
The long-term objective of the studies encompassing these preliminary 
experiments is to characterize potential molecular markers that can be useful in 
the diagnosis of the early stages of AD. Since AD is a multifactorial disorder, the 
use of a single marker is unlikely to be of value. Therefore, the use of a carefully 
selected combination of markers should allow for more accurate diagnosis. The 
results described, although not conclusive, can provide clues as to how some 
proteins are respond to different types of stress linked to the pathogenesis of AD. In 
a preliminary approach we can say that under extreme stress conditions (sodium 
azide and heat shock experiments) there was a decrease in APP expression, in 
particular on the 751/770 isoforms, for both cell lines (Figures 8 and 9, I ), 
accompanied by a substantial increase in PARP cleavage (apoptosis). 
Apparently, the APP695 isoform is less sensitive to stress than the APP751/770 isoforms. 
Hence, APP may constitute itself an interesting molecular diagnostic tool for AD. 
The other proteins monitored (PP1, HSP70 and PARP) could potentially also turn out 
to be useful markers. Clearly, the proteins studied do not represent an extensive 
array of all potential molecular protein markers for AD. Nonetheless, this approach 
may identify potential molecular markers useful for the early AD diagnosis and 
other dysfunctions. 
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5.6 Final conclusions 
 
From the experiments presented here several conclusions can be drawn: 
 
1. Different cell lines respond differently to the same stress, both 
in terms of protein processing and altered protein expression. 
Essentially, upon addition of sodium azide PC12 cell viability 
is more readily affected, whereas in terms of APP processing 
and increased processing in the presence of phorbol esters, 
COS-1 cells appear to be more sensitive. 
2. Short term treatment of cells with sodium azide appears to 
be toxic on several levels, namely, APP processing, APP 
maturation and cell viability. 
3. Different APP isoforms respond differently to similar insults. For 
example, band shift in response to 2DG addition, is more 
pronounced for the 751/770 isoforms. Again the same 
isoforms appears to be more sensitive, disappearing upon 
exposure to e.g. NaN3. 
4. PMA induction of sAPP is maintained under conditions of 
stress but OA induction is abolished. It would appear 
therefore that one can dissociate APP processing pathways 
under conditions of stress. This may have implications for AD 
patients whose cells are under stress. 
5. Exposure to sodium azide and heat shock appear to 
constitute more aggressive stresses than exposure to Abeta 
peptides. 
6. Addition of Abeta 25-35 causes increased APP expression. 
This can be of significant pathological consequence since 
neuronal cells can be exposed to Abeta to varying degrees. 
7. Finally, the methodology presented identified molecular 
markers for cellular stress, potentially useful in AD. Clearly 
further work is necessary in order to validate these results in a 
more applied setting. 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
60 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
6. BIBLIOGRAPHY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
61 
Abe, K., St. George-Hyslop, P. H., Tanzi, R. E. and Kogure, K. (1991). Induction of 
amyloid precursor protein mRNA after heat shock in cultured human 
lymphoblastoid cells. Neurosci. Lett. 125, 169-171. 
 
Alzheimer, A. (1907). Uber eine eigenartige Erkankung der Hirnrinde. Allg. Zschr. F 
Psychiatr. Psychisch-Gerichlt. Mediz. 64, 146-148. 
 
Aurelio, O. N., Kong, X. T., Gupta, S. and Stanbridge, E. J. (2000). p53 mutants have 
selective dominant-negative effects on apoptosis but not growth arrest in human 
cancer cell lines. Mol. Cell. Biol. 20, 770-778. 
 
Beere, H. M. (2001). Stressed to death: regulation of apoptotic signalling pathways 
by the heat-shock proteins. SciSTKE. 2001(93), RE1. 
 
Behl, C., Davis, J. B., Lesley, R. and Schubert, D. (1994). Hydrogen peroxide 
mediates amyloid beta protein toxicity. Cell 77, 817-827. 
 
Blass, J. P., Baker, A. C., Ko, L. and Black, R. S. (1990). Induction of Alzheimer 
antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol . 47, 846-869. 
 
Burnette, W. N. (1981). “Western blotting”: electrophoretic transfer of proteins from 
sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and 
radiographic detection with antibody and radioiodinated protein A. Anal. 
Biochem. 112; 195. 
 
Butterfield, D. A. (1997). Beta-Amyloid-associated free radical oxidative stress and 
neurotoxicity: implications for Alzheimer´s disease. Chem. Res. Toxicol . 10, 495-506. 
 
Butterfield, D. A., Drake, J., Pocernich, C. and Castegna, A. (2001). Evidence for 
oxidative damage in Alzheimer´s disease brain: central role for amyloid ?-peptide. 
TRENDS Mol. Med. 7, 548-554. 
 
Buxbaum, J. D., Gandy, S. E., Cicchetti, P., Ehrlich, M. E., Czernick, A. J., Fracasso, 
R. P., Ramabhadran, T. V., Unterbeck, A. J. and Greengard, P. (1990). Processing 
of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that 
regulate protein phosphorylation. Proc. Natl. Acad. Sci. USA 87, 6003-6006. 
 
Buxbaum, J. D., and Greengard, P. (1996). Regulation of APP processing by intra- 
and intercellular  signals. Ann. NY Acad. Sci. 777, 327-331. 
 
Buxbaum, J. D., Koo, E. H. and Greengard, P. (1993). Protein phosphorylation 
inhibits production of Alzheimer amyloid beta/A4 peptide. Proc. Natl. Acad. Sci. 
USA 90, 9195-9198. 
 
Buxbaum, J. D., Liu, K. N., Luo, Y., et al. (1998). Evidence that tumor necrosis factor 
alpha converting enzyme is involved in regulated alpha-secretase cleavage of 
the Alzheimer amyloid precursor protein. J. Biol. Chem. 273, 27765-27767. 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
62 
Cai, X.-D., Golde, T. E. and Younkin, S. G. (1993). Release of excess amyloid ?  
protein from a mutant amyloid ?  protein precursor. Science 259, 514-516. 
 
Caporaso, G. L., Gandy, S. E., Buxbaum, J. D., Ramabhadran, T. V. and 
Greengard, P. (1992). Protein phosphorylation regulates secretion of Alzheimer 
beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 3055-3059. 
 
Caputi, A., Barindelli, S., Pastorino, L., Cimino, M., Buxbaum, J. D., Cattabeni, F. and 
Di Luca, M. (1997). Increased secretion of the amino-terminal fragment of amyloid 
precursor protein in brains of rats with a constitutive up-regulation of protein kinase 
C. J. Neurochem. 68, 2523-2529. 
 
Carrell, R. W. and Lomas, D. A. (1997). Conformational disease. Lancet 50(9071), 
134-138. 
 
Carter, J. and Lippa, C. F. (2001). Beta-amyloid, neuronal death and Alzheimer´s 
disease. Curr. Mol. Med. 1(6), 733-777. 
 
Chartier-Harlin, M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., 
et al. (1991). Early-onset Alzheimer’s disease caused by mutations at codon 717 of 
the ?-amyloid.precursor protein gene. Nature 353, 844-846. 
 
Checler, F. (1995). Processing of the ?-amyloid protein and its regulation in 
Alzheimer´s disease. J. Neurochem. 65, 1431-1444. 
 
Chinopoulos, C., Tretter, L. and Adam-Vizi, V. (1999). Depolarization of in situ 
mitochondria due to hydrogen peroxide-induced oxidative stress in nerve 
terminals: inhibition of alpha-ketoglutarate dehydrogenase. J. Neurochem. 73, 
220-228. 
 
Citron, M., Oltersdorf, T, Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-
Pelfrey, C., Lieberburg, I. and Selkoe, D. J. (1992). Mutation of the ?-amyloid 
precursor protein in familial Alzheimer´s disease increases ?-amyloid production. 
Nature 360, 672-674. 
 
Colton, C. A. and Gilbert, D. L. (1987). Production of superoxide anions by a CNS 
macrophage, the microglia. FEBS Lett. 223, 284-288. 
 
da Cruz e Silva, E. F., da Cruz e Silva, O. A. B., Zaia, C. T. V. and Greengard, P. 
(1995a). Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer 
amyloid precursor protein. Mol. Med. 1, 535-541.  
 
da Cruz e Silva. E. F., Fox. C. A., Ouimet. C. C., Gustafson. E., Watson. S. J. and 
Greengard, P. (1995b). Differential expression of protein phosphatase 1 isoforms in 
mammalian brain. J. Neurosci. 15, 3375-3389.  
 
da Cruz e Silva, O. A. B., Iverfeldt, K., Oltersdorf, T., Sinha, S., Lieberburg, I., 
Ramabhadran, T. V., Suzuki, T., Sisodia, S. S., Gandy, S. and Greengard, P. (1993). 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
63 
Regulated cleavage of Alzheimer beta-amyloid precursor protein in the absence 
of the cytoplasmic tail. Neuroscience 57, 873-877. 
 
da Cruz e Silva,  O. A. B., Fardilha, M., Henriques, A. G., Rebelo, S., Guerra e Paz, S. 
and Da Cruz e Silva, E. F. (2003). Signal transduction therapeutics: A novel 
approach in Alzheimer´s disease. J. Mol. Neurosci. (in press). 
 
Davis, R. E., Miller, S., Herrnstadt, C., Ghosh, S. S., Hahy, E., Shinobu, L. A., Galasko 
D., Thal, L. J., Beal, M. F., Howell, N. and Parker, W. D. Jr. (1997). Mutations in 
mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer 
disease. Proc. Natl. Acad. Sci. USA 94, 4526-4531. 
 
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, 
W., Von Figura, K. and Van Leuven, F. (1998). Dificiency of preselinin-1 inhibits the 
normal cleavage of amyloid precursor protein. Nature 391, 387-390. 
 
Dikalov, S. I., Vitek, M. P., Maples, K. R. and Mason, R. P. (1999). Amyloid beta 
peptides do not form peptide-derived free radicals spontaneously, but can 
enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 
274, 9399. 
 
Dodart, J. C., Mathis, C., and Ungerer, A. (2000). The beta-amyloid precursor 
protein and its derivates: from biology to learning and memory processes. Rev. 
Neurosci . 11, 75-93. 
 
Dragunow, M., Faull, R. L., Lawlor, P., Beilharz, E. J., Singleton, K., Walker, E. B., et al. 
(1995). In situ evidence for DNA fragmentation in Huntington´s disease striatum 
and Alzheimer´s disease temporal lobes. Neuroreport 6, 1053-1057. 
 
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-tur, J., Hutton, M., Buee, L., 
Harigaya, Y., Yager, D., et al. (1996). Increased amyloid-beta42(43) in brains of 
mice expressing mutant presenilin 1. Nature 383, 710-713. 
 
Ebinu, J. O., and Yankner, B. A. (2002). A RIP tide in neuronal signal transduction. 
Neuron 34, 499-502. 
 
Edelberg, H. K. and Wei, J. Y. (1996). The biology of Alzheimer´s disease. Mech. 
Ageing Dev. 91, 95-114. 
 
Esler, W. P. and Wolfe, M. S. (2001). A portrait of Alzheimer secretases-new features 
and familial faces. Science 293, 1449-1454. 
 
Frederikse, P. H., Garland, D., Zigler, J. S. and Piatigorsky, J. (1996). Oxidative stress 
increases production of beta-amyloid precursor protein and beta amyloid 
(Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. 
J. Biol. Chem. 271, 10169-10174. 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
64 
Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P. and Yankner, B. A. (1994). 
Inhibition of energy metabolism alters the processing of the amyloid precursor 
protein and induces a potentially amyloidogenic derivate. J. Biol. Chem. 269, 
13623-13628. 
 
Gabuzda, D., Busciglio, J. and Yanker, B. A. (1993). Inhibition of beta-amyloid 
production by activation of protein kinase C. J. Neurochem. 61, 2326-2329. 
 
Galli, C., Piccini, A., Ciotti, M. T., Castellani, L., Calissano, P., Zaccheod, D. and 
Tabaton, M. (1998). Increased amyloidogenic secretion in cerebrall granule cells 
undergoing apoptosis. Proc. Natl. Acad. Sci. USA 85, 1247-1252. 
 
Gandy, S. E., Czernik, A. J. and Greengard, P. (1988). Phosphorylation of Alzheimer 
disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-
dependent protein kinase II. Proc. Natl. Acad. Sci. USA 85, 6218-6221. 
 
Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, 
M. and Govoni, S. (1997). Effect of energy shortage and oxidative stress on 
amyloid precursor protein metabolism in COS cells.  Neurosci. Lett. 231(2), 113-117. 
 
Genoux, D., Haditsch, V., Knobloch, M., Michalon, A., Storm, D. and Mansuy, I. M. 
(2002). Protein phosphatase 1 is a molecular constraint on learning and memory. 
Nature 418, 970-975.  
 
Gibson, G. E. (2002). Interactions of oxidative stress with cellular calcium dynamics 
and glucose metabolism in Alzheimer´s disease. Free Radic. Biol. Med. 32, 1061-
1070. 
 
Gibson, G., Martins, R., Blass, J. and Gandy, S. (1996). Atered oxidation and signal 
transduction systems in fobroblasts from Alzheimer´s patients. Life Sci. 59, 477-489. 
 
Gibson, G. E., Park, L. C., Sheu, K. F., Blass, J. P. and Calingasan, N. Y. (2000). The 
alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem. 
Int. 36, 97-112. 
 
Glenner, G. G. and Wong, C. W. (1984). Alzheimer disease: initial report of the 
purification and characterization of a novel cerebrovascular amyloid protein. 
Biochem. Biophys. Res. Commun. 120, 885-890. 
 
Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. 
(1991). Segregation of a missence mutation in the amyloid precursor protein gene 
with familial Alzheimer’s disease. Nature 349, 704-706. 
 
Goedert, M. (1987). Neuronal localization of amyloid ?  protein precursor mRNA in 
normal human brain and in Alzheimer´s disease. EMBO J. 6, 3627-3632. 
 
Goedert, M., Spillantini, M. G., Cairns, N. J. and Crowther, R. A. (1992). Tau proteins 
of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain 
isoforms. Neuron 8, 159-168. 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
65 
Gong, C. X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I. and Iqbal, K. (2000). 
Phosphorylation of microtubule-associated protein tau is regulated by protein 
phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration 
in Alzheimer's disease. J. Biol. Chem. 275, 5535-5544. 
 
Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P. and Ball, 
M. J. (1994). Chemical characterization of A?17-42 peptide, a component of 
difuse amyloid deposits of Alzheimer´s disease. J. Biol. Chem. 269, 10987-10990. 
 
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M. and Binder, L. 
I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau in 
Alzheimer cytosKeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917. 
 
Grütter, M. G. (2000). Caspases: key players in programmed cell death. Current 
Opinion Struct. Biol. 10, 649-655. 
 
Haas, J., Storch-Hagenlocher, B., Beissmann, A. and Wildemann, B. (2002). 
Inducible nitric oxide syntethase and argininosuccinate synthetase: co-induction 
in brain tissue of patients with Alzheimer´s dementia and following stimulation with 
beta-amyloid 1-42 in vitro. Neurosci. Lett. 322, 121-125. 
 
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., 
Ostaszewski, B. L. et al. (1992). Amyloid ?-peptides produced by cultured cells 
during normal metabolism. Nature 359, 322-325. 
 
Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L. 
and Selkoe, D. J. (1995). The Swedish mutation causes early-onset Alzheimer´s 
disease by ?-secretase cleavage within secretory pathway. Nature Med. 1, 1291-
1296. 
 
Harada, J. and Sugimoto, M., (1999). Activation of caspase-3 in beta-amyloid 
induced apoptosis of cultured rat cortical neurons. Brain Res. 842, 311-323. 
 
Hardy, J. and Allsop, D. (1991). Amyloid deposition as the central event in 
aetiology of Alzheimer’s disease. Trends Pharmacol. Sci. 12, 383-388. 
 
Hedin, H. L. and Fowler, C. J. (200). Effects of sodium azide on the secretion of 
soluble amyloid-beta precursor protein and the accumulation of beta-amyloid(1-
40) in cultured chick neurons. Neurosci. Lett.  288, 203-206. 
 
Herceg, Z. and Wang, Z. (1999). Failure of poly(ADP-ribose) polymerase cleavage 
by caspases leads to induction of necrosis and enhanced apoptosis. Mol. Cell. 
Biol. 19, 5124-5133. 
 
Holtzman, D. M. (2001). Role of ApoE/Abeta interactions in the pathogenesis of 
Alzheimer´s disease and cerebral amyloid angiopathy. J. Mol. Neurosci. 17, 147-
155. 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
66 
Hölscher, C. (1998). Possible causes of Alzheimer´s disease: Amyloid fragments, 
free radicals, and calcium homeostasis. Neurobiol. Dis. 5, 129-141. 
 
Hu, J., Akama, k. T., Krafft, G. A., Chromy, B. A. and Van Eldik, L. J. (1998). Amyloid-
beta peptide activates cultured astrocytes: morphological alterations, cytokine 
induction and nitric oxide release. Brain Res. 785, 195-206. 
 
Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, 
R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E. and Bush, A. I. 
(1999). The Abeta peptide of Alzheimer´s disease directly produces hydrogen 
peroxide through metal ion reduction.  Biochemistry 38, 7609-16. 
 
Hung, A. Y., and Selkoe, D. J. (1994). Selective ectodomain phosphorylation and 
regulated cleavage of beta-amyloid precursor protein. EMBO J. 13, 534-542.  
 
Huse, J. T., Pijack, D. S., Leslie, G. J., Lee, V. M.-Y., and Doms, R. W. (2000). 
Maturation and endosomal targeting of ?-site amyloid precursor protein-cleaving 
enzyme. J. Biol. Chem. 275, 33729-33737. 
 
Iwatsubo, T., Okada, A., Susuki, N., Mizusawa, H., Nukina, N. and Ihara, Y. (1994). 
Visualization of A beta 42 (43) and A beta 40 in senile plaques with end-specific A 
beta monoclonals: evidence that an initially deposited species is A beta 42. 
Neuron 13, 45-53. 
 
Jacobsen, J. S., Spruyt, M. A., Brown, A. M., Sahasrabudhe, S. R., Blume, A. J., Vitek, 
M. P., Muenkel, H. A. and Sonnenberg-Reines, J. (1994). The release of Alzheimer's 
disease beta amyloid peptide is reduced by phorbol treatment. J. Biol. Chem. 
269, 8376- 8382. 
 
Johnson, D. A., Gautsch, J. W., Sportsman, J. R. and Elder, J. H. (1984). Improved 
technique utilizing nonfat dry milk for analysis of proteins and nucleic acids 
transferred to nitrocellulose. Gene Anal. Tech., 1; 3. 
 
Johnson, G., Refolo, L. M. and Wallace, W. (1993). Heat-shocked neuronal PC12 
cells reveal Alzheimer's disease-associated alterations in amyloid precursor protein 
and tau. Ann. NY Acad. Sci. 695, 194-197. 
 
Kakimura, J. I., Kitamura, Y., Takata, K., Umeki, M., Suzuki, S., Shibagaki, K., 
Taniguchi, T., Nomura, Y., Gebicke-Haerter, P. J., Smith, M. A., Perry, G.  and 
Shimohama, S. (2002). Microglial activation and amyloid-beta clearance induced 
by exogenous heat-shock proteins. FASEB. J. 16, 601-603. 
 
Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Master, C. L., Grzeschik, K. 
H., Multhaup, G., Beyreuther, K. and Muller-Hill, B. (1987). The precursor of 
Alzheimer´s disease amyloid A4 protein resembles a cell surface receptor. Nature 
325, 733-736. 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
67 
Kienlen-Campard, P., Miolet, S., Tasiaux, B. and Octave, J. N. (2002). Intracellular 
amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces 
neuronal apoptosis. J. Biol. Chem. 277, 15666-15670. 
 
Kim, T. W., Pettingell, W. H., Jung, Y. K., Kovacs, D. M. and Tanzi, R. E. (1997). 
Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a 
caspase-3 family protease. Science 277, 373-376. 
 
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L. J., 
Wilson, J. M., DiStefano, L. M. and Nobrega, J. N. (1992). Brain cytochrome oxidase 
in Alzheimer´s disease. J. Neurochem. 59, 776-779. 
 
Kosik, K. S. (1993). Alzheimer´s disease: a cell biological perspective, Science 256, 
780-783. 
 
Kosik, K. S., Qiu, W. Q., and Greenberg, S. (1996). Cellular signalling pathways and 
cytoskeletal organization. Ann. NY Acad. Sci. 777, 114-120. 
 
Kowall, N.W., Mckee, A. C., Yanker, B. A. and Beal, M. F. (1992). In vivo 
neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. 
Neurobiol. Aging 13, 537-42. 
 
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 227; 680-685. 
 
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., 
Markesbery, W. R. and Butterfield, D. A. (2001). The glial glutamate transporter, 
GLT-1, is oxidatively modified by 4-hidroxy-2-nonenal in the Alzheimer´s disease 
brain: the role of A?1-42. J. Neurochem. 78, 413-416. 
 
Lauderback, C. M., Kanski, J., Hackett, J. M., Maeda, N., Kindy, M. S. and 
Butterfield, D. A. (2002). Apolipoprotein E modulates Alzheimer A?(1-42)-induced 
oxidative damage to synaptosomes in an allele-specific manner. Brain Res. 924, 
90-97. 
 
LeBlanc, A. C. (1995). Increased production of 4KDa amyloid beta peptide in 
serum deprived human primary neuron cultures: possible involvement of 
apoptosis. J. Neurosci. 15, 7837-7846. 
 
LeBlanc, A. C., Chen, H., Autilio-Gambetti, L. and Gambetti, P. (1991). Differential 
APP gene expression in neonatal rat cerebral cortex, meninges and primary 
astroglial, neuronal and microglial cell. FEBS Lett. 292, 171-178. 
 
Leutz, S., Steiner, B., Marques, C. A., Haass, C., Muller, W. E. and Eckert, A. (2002). 
Reduction of trophic support enhances apoptosis in PC12 cells expressing 
Alzheimer´s APP mutation and sensitizes cells to staurosporine-induced cell death. 
J. Mol. Neurosci. 18, 189-201. 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
68 
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P. and Halliwell, B. (1997). An assessment 
of oxidative damage to proteins, lipids, DNA in brain from patients with Alzheimer´s 
disease. J. Neurochem. 68, 2061-2069. 
 
Loetscher, H., Deuschle, U., Brockhaus, M., Reinhardt, D., Nelboeck, P., Mous, J., 
Grunberg, J., Haass, C. and Jacobsen, H. (1997). Presenilins are processed by 
caspase-type proteases. J. Biochem. Chem. 272, 20655-20659. 
 
Lorenzo, A. and Yankner, B. A. (1994). Beta-amyloid neurotoxicity requires fibril 
formation and is inhibited by congo red.  Proc. Natl. Acad. Sci. USA 91, 12243-2247. 
 
Love, S., Barber, R. and Wilcock, G. K. (1999). Increased poly(ADP-ribosyl)ation of 
nuclear proteins in Alzheimer´s disease. Brain 122, 247-253. 
 
Lukiw, W. J. and Bazan, N. G. (2000). Neuroinflammatory signalling upregulation in 
Alzheimer´s disease. Neurochem. Res. 25, 1173-1184. 
 
McFarlane, I ., Georgopoulou. N., Coughlan, C. M., Gillian, A. M. and Breen, K. C. 
(1999). The role of the protein glycosylation state in the control of cellular transport 
of the amyloid beta precursor protein. Neurosc. 90,15-25 
 
Markesbery, W. R. (1997). Oxidative stress hypothesis in Alzheimer´s disease. Free 
Radic. Biol. Med. 23, 134-147. 
 
Markesbery, W. R. and Carney, J. M. (1999). Oxidative alterations in Alzheimer´s 
disease. Brain Pathol. 9, 133-146. 
 
Mattson, M. P. (1999). Impairment of membrane transport and signal transduction 
systems by amyloidogenic proteins. Methods Enzymol. 309, 733-746. 
 
Mattson, M. P., Fu, W., Waeg, G., Uchida, K. (1997). 4-hydroxynonenal, a product 
of lipid peroxidation, inhibits dephosphorylation of microtubule-associated protein 
tau. Neuroreport 8, 2275-2281. 
 
Mattson, M. P., Partin, J. and Begley, J. G. (1998). Amyloid beta-peptide induces 
apoptosis-related events in synapses and dendrites. Brain Res. 807(1-2), 167-176. 
 
Mills, J., Laurent Charest, D., Lam, F., Beyreuther, K., Ida, N., Pelech, S. L. and 
Reiner, P. B. (1997). Regulation of amyloid precursor protein catabolism involves 
the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17, 
9415-9422. 
 
Mills, J. and Reiner, P. B. (1999). Short review: Regulation of Amyloid Precursor 
Protein Cleavage. J. Neurochem. 72, 443-460. 
 
Misonou, H., Morishima-Kawashima, M. and Ihara, Y. (2000). Oxidative stress 
induces intracellular accumulation of amyloid beta-protein (Abeta) in human 
neuroblastome cells.  Biochemistry 39, 6951-6959. 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
69 
Mosser, D. D., Caron, A. W., Bourget, L., Denis-Larose, C. and Massie, B. (1997). Role 
of the human heat-shock protein hsp70 in protection against stress-induced 
apoptosis. Mol. Cell. Biol. 17, 5317-5327. 
 
Mossman, T. (1983). Rapid colorimetric assay for cellular growth and survival: 
application to proliferation and cytotoxic assays. J. Immunol. Methods 65; 55-63. 
 
Muchowski, P. J., Schaffar, G., Sittler, A., Wanker, E. E., Hayer-Hartl, M. K. and Hartl, 
F. U. (2000). Hsp70 and hsp40 chaperones can inhibit self assembly of 
polyglutamine proteins into amyloid-like fibrils. Proc. Natl. Acad. Sci. USA 97, 7841-
7846. 
 
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. and 
Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer´s disease in the 
APP gene at N-terminus of ?-amyloid. Nat. Genet. 1, 345-347. 
 
Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. (1991). A mutation in the 
amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 
254, 97-99. 
 
Mutisya, E. M., Bowling, A. C. and Beal, M. F. (1994). Cortical cytochrome oxidase 
activity is reduced in Alzheimer´s disease. J. Neurochem. 63, 2179-2184. 
 
Nitsch, R. M. and Growdon, J. H. (1994). Role of neurotransmission in the regulation 
of amyloid ?-protein precursor processing. Biochem. Pharmacol . 47, 1275-1284. 
 
Nitsch, R. M., Deng, M., Growdon, J. H. and Wurtman, R. J. (1996). Serotonin 5-HT2a 
and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. 
J. Biol. Chem. 271, 4188-4194. 
 
Nitsch, R. M., Slack, B. E., Farber, S. A., Borghesani, P. R., Schulz, J. G., Kim, C., 
Felder, C. C., Growdon, J. H. and Wurtman, R. J. (1994). Receptor-coupled 
amyloid precursor protein processing. Ann. NY Acad. Sci. 881, 122-127. 
 
Nguyen, T. T. and Amara, S. G. (1996). N-linked oligosaccharides are required for 
cell surface expression of the norepinephrine transporter but do not influence 
substrate or inhibitor recognition. J. Neurochem. 67, 645-655. 
 
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K:, 
Ghanbari, H., wataya, T., Shimohama, S. et al. (2001). Oxidative damage is the 
earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol . 60, 759-767. 
 
Oishi, M., Nairn, A. C., Czernik, A. J., Lim, G. S., Isohara, T., Gandy, S. E., Greengard, 
P. and Suzuki, T. (1997). The cytoplasmic domain of Alzheimer´s amyloid precursor 
protein is phosphorylated at Thr654, Ser655 and Thr668 in adult rat brain and 
cultured cells. Mol. Med. 3, 111-123. 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
70 
Olivieri, G., Baysang, G., Meier, F., Muller-Spahn, F., Stahelin, H. B., Brockhaus, M. 
and Brack, C. (2001). N-acetyl-L-cysteine protects SHSY5Y neuroblastome cells 
from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and 
tau phosphorylation. J. Neurochem. 76, 224-233. 
 
Ouimet, C. C., da Cruz e Silva, E. F. and Greengard, P. (1995). The alpha and 
gamma 1 isoforms of protein phosphatase 1 are highly and specifically 
concentrated in dendritic spines. Proc. Natl. Acad. Sci. USA 92, 3396-3400.  
 
Pahlson, P. and Spitalnik, S. L. (1996). The role of glycosilation in synthesis and 
secretion of beta-amyloid precursor protein by Chinese hamster ovary cells. Arch. 
Biochem. Biophys. Res. Comm. 189, 1667-1673. 
 
Parker, W. D. Jr., Mahr, N. J., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A. and 
Cullum, C. M. (1994). Reduced platelet cytochrome c oxidase activity in 
Alzheimer´s disease. Neurology 44, 1086-1090. 
 
Parks, J. K., Smith, T. S., Trimmer, P. A., Jr Bennett, J. P. and Jr Parker, W. D. (2001). 
Neurotoxic A?  peptides increase oxidative stress in vivo through NMDA-receptor 
and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce 
a mitochondrial permeability transition in vitro. J. Neurochem. 76, 1050-1056. 
 
Pellegrini, L., Passer, B. J., Tabaton, M., Ganjei, J. K. and D´Adamio, L. (1999). 
Alternative, non-secretase processing of Alzheimer´s beta-amyloid precursor 
protein during apoptosis by caspase-6 and –8. J. Biol. Chem. 274, 21011-21016. 
 
Perry, G., Cash, A. D. and Smith, M. A. (2002). Alzheimer Disease and Oxidative 
Stress. J. Biomed. Biotechnol . 2, 120-123. 
 
Pike, C. J., Cummings, B. J. and Cotman, C. W. (1992). Beta-Amyloid induces 
neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3, 769-
772. 
 
Pike, C. J., Overman, M. J. and Cotman, C. W. (1995). Amino-terminal deletions 
enhance aggregation of ?-amyloid peptides in vitro. J. Biol. Chem. 270, 23895-
23898. 
 
Prasad, K. N., Cole, W. C. and Prasad, K. C. (2002). Risk factors for Alzheimer´s 
disease: role of multiple antioxidants, non-steroidal anti-inflammatory and 
cholinergic agents alone or in combination in prevention and treatment. J. 
American Coll. Nutri. 21, 506-522. 
 
Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. Q. and Lee, V. M. (2001). Increased 
lipid peroxidation precedes amyloi plaque formation in an animal model of 
Alzheimer amyloidosis. J. Neurosci . 21, 4183-4137. 
 
Price, D. L., Borchelt, D. R. and Sisoda, S. S (1993). Alzheimer disease and the prion 
disorders amyloid ?-protein and prion protein amyloidoses. Proc. Natl. Acad. Sci. 
USA 90, 6381-6384. 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
71 
Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P. and de Jong, W. W. 
(1994). Expression of alpha B-crystallin in Alzheimer´s disease. Acta Neuropathol. 
(Berl) 87, 155-160. 
 
Richard, F. and Amouyel, P. (2001). Genetic susceptibility factors for Alzheimer’s 
Disease. Eur. J. Pharmacol. 412, 1-12. 
 
Tanzi, R. E., Kovacs, D. M., Kim, Tae-Wan, Moir, R. D., Guenette, S. Y. and Wasco, W. 
(1996). The gene defects responsible for familial Alzheimer´s disease. Neurobiol. 
Dis. 3, 159-168. 
 
Sabo, S. L., Lanier, L. M., Ikin, A. F., Khorkova, O., Sahasrabudhe, S., Greengard, P. 
and Buxbaum, J. D. (1999). Regulation of beta-amyloid secretion by FE65, an 
amyloid protein precursor-binding protein. J. Biol. Chem. 274, 7952-7957. 
 
Savage, M. J., Trusko, S. P., Howland, D. S., Pinsker, L. R., Mistretta, S., Reaume, A. 
G., Greenberg, B. D., Siman, R. and Scott, R. W. (1998). Turnover of amyloid ?-
protein in mouse brain and acute reduction of its level by phorbol ester. J. 
Neurosci . 18, 1743-1752. 
 
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., 
Hardy, J., Hutton, M., Kukull, W., Larson, E. et al ., (1996). Secreted amyloid beta-
protein similar to that in the senile plaques of Alzheimer´s disease is increased in 
vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer´s 
disease. Nat. Med. 2, 864-870. 
 
Selkoe, D. J. (1994). Cell biology of the amyloid beta-protein precursor and the 
mechanism of Alzheimer´s disease. Annu. Rev. Cell Biol . 10, 373-403. 
 
Selkoe, D. J. (1997). Alzheimer´s disease: Genotypes, phenotype, and treatments. 
Science 275, 630-632. 
 
Selkoe, D. J. and Kopan, R. (2003). Notch and presenilin: regulated 
intramembrane proteolysis links development and degeneration. Annu. Rev. 
Neurosci. [epub ahead of print]. 
 
Selkoe, D. J., Yamazaki, M., Citron, M., Podlisny, M. B., Koo, E. H., Teplow, D. B. and 
Haass, C. (1996). The role of APP processing and trafficking pathways in the 
formation of amyloid ?-protein. Ann. NY Acad. Sci. 777, 57-64. 
 
Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T. and Kato, K. (1993). Alpha B 
crystallin and HSP28 are enhanced in the cerebral cortex of patients with 
Alzheimer´s disease. J. Neurol. Sci . 119, 155-160. 
 
Smith, M. A., Harris, P. L. R., Sayre, L. M. and Perry, G. (1997). Iron accumulation in 
Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad 
Sci USA. 94, 9866-9868. 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
72 
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K. and Perry, G. (2000). 
Oxidative stress in Alzheimer´s disease. Biochim. Biophys. Acta 1502, 139-144. 
 
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, 
M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J. and Klenk, D. C. (1985). 
Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85. 
 
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., et al. (1992). 
Production of the Alzheimer amyloid ?  protein by normal proteolytic processing. 
Science 258, 126-129. 
 
SOti, C. and Csermely, P. (2000). Molecular chaperones and the aging process. 
Biogerontology 1, 225-233. 
 
Soto, C. (1999). Alzheimer's and prion disease as disorders of protein conformation: 
Implications for the design of novel therapeutic approaches. J. Mol. Med. 77, 412-
418.  
 
Strosznajder, J. B., J sko, H. and Strosznajder R. P. (2000). Effect of amyloid beta 
peptide on poly(ADP-ribose) polymerase activity in adult and aged rat 
hippocampus. Acta. Biochimi. Pol. 47, 847-854. 
 
Su, J. H., Anderson, A. J., Cummings, B. J. and Cotman, C. W. (1994). 
Immunohistochemical evidence for apoptosis in Alzheimer´s disease. Neuroreport, 
5, 2529-2533. 
 
Suzuki, T., Oishi, M., Marshak, D. R., Czernik, A. J., Nairn, A. C. and Greengrad, P. 
(1994). Cell cycle-dependent regulation of the phosphorylation and metabolism 
of the Alzheimer amyloid precursor protein. EMBO J. 13, 1114-1122. 
 
Tan, S., Maher, P. and Schubert, D. (1997). The role of protein phosphorylation in 
beta amyloid toxicity. Brain Res. 765, 159-163. 
 
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A., St. George-Hyslop, P., Van 
Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M. and Neve, R. L. (1987). Amyloid 
?  protein gene: cDNA, mRNA distribution and genetic linkage near Alzheimer 
locus. Science 235, 880-884. 
 
Tanzi, E. R., Kovacs, D. M., Kim, T., Moir, R. D., Guenette, S. Y. and Wasco, W. (1996). 
The gene defects responsible for familial Alzheimer´s disease. Neurobiol. Dis. 3, 159-
168. 
 
Tanzi, R. E., Vaula, G., Romano, D. M., Mortilla, M., Huang, T. L., Tupler, R. G., 
Wasco, W., Hyman, B. T., Haines, J. L., Jenkins, B. J. et al. (1992). Assessment of 
amyloid beta-protein precursor gene mutations in a large set of familial and 
sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51, 273-82. 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
73 
Tewari, M., Quan, L. T., O´Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. 
G., Salvesen, G. S. and Dixit, V. M. (1995). Yama/CPP32B, a mammalian homolog 
of CED-3, is a Crm-Ainhibitable protease that cleaves the death substrate 
poly(ADP-ribose) polymerase. Cell 81, 801-809. 
 
Troncoso, J. C., Sukhov, R. R., Kawas, C. H. and Koliatsos, V. E. (1996). In situ 
labeling  of dying cortical neurons in normal aging and in Alzheimer´s disease: 
correlations with senile plaques and disease progression. J. Neuropathol. Exp. 
Neurol. 55, 1134-1142. 
 
Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C. and Butterfield, D. A. 
(2001). Different mechanisms of oxidative stress and neurotoxicity for Alzheimer´s 
abeta (1-42) and abeta (25-35). J. Am. Chem. Soc. 123, 5625-5631. 
 
Varadarajan, S., Yatin, S., Aksenova, M. and Butterfield, D. A. (2000). Review: 
Alzheimer´s amyloid beta-peptide-associated free radical oxidative stress and 
neurotoxicity. J. Struct.Biol. 130, 184-208. 
 
Vassar, R., Bennet, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, 
D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, 
J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J., Collins, F., Treanor, J., 
Rogers, G. and Citron, M. (1999). Beta-secretase cleavage of Alzheimer´s amyloid 
precursor protein by the transmembrane aspartic protease BACE. Science 286, 
735-741. 
 
Vickers, J. C., Dickson, T. C., Adlard, P. A., Saunders, H. L., King, C. E. and 
McCormack, G. (2000). The cause of neuronal degeneration in Alzheimer´s 
disease. Prog. Neurobiol. 60(2), 139-165. 
 
Wang, J., Dickson, D. W., Trojanowski, J. Q., and Lee, V. M. (1999). The levels of 
soluble versus insoluble brain Abeta distinguish Alzheimer´s disease from normal 
and pathological aging. Exp. Neurol . 158, 328-337. 
 
Weidemann, A., Konig, G., Bunke, D., Fisher, P., Salbaum, J. M., Masters, C. L. and 
Beyreuther, k. (1989). Identification, biogenesis, and localization of precursors of 
Alzheimer´s disease A4 amyloid protein. Cell 57, 115-126. 
 
Whitehead, T. P., Kricha, L. J., Carter, T. J. and Thorpe, G. H. (1979). Analytical 
luminescence: its potential in the clinical laboratory. Clin. Chem. 25, 1531-1546. 
 
Williams, B. R. (2001). Geriatric dementias. In: Koda Kimble, M. A., Young, L. Y. Eds. 
Applied therapeutics: the clinical use of drugs,  7th edn. Lippincott: Williams & 
Wilkins, 98.1-98.9. 
 
Xu, H., Jeitner, T., Zhang, H. and Gibson, G. E. (2001). J. Neurochm. 78S, 32. 
 
Yankner, B. A., Caceres, A. and Duffy, L. K. (1990). Nerve growth factor potentiates 
the neurotoxicity of beta amyloid. Proc. Natl. Acad. Sci. USA 87, 9020-9023. 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
74 
Yatin, S. M., Yatin, M., Varadarajan, S., Ain, K. B: and Butterfield, D. A. (2001). Role 
of spermine in amyloid ?-peptide-associated free radical-induced neurotoxicity. J. 
Neurosci. Res. 63, 395-401. 
 
Yatin, S. M., Varadaranjan, S., Link, C. D. and Butterfield, D. A. (1999). In vitro and in 
vivo oxidative stress associated with Alzheimer´s amyloid beta-peptide (1-42). 
Neurobiol. Aging 20, 325-330. 
 
Yoo, B. C., Kim, S. H., Cairns, N., Fountoulakis, M. and Lubec, G. (2001). Deranged 
expression of molecular chaperones in brains of patints with Alzheimer´s disease. 
Biochem. Biophys. Res. Commun. 280, 249-258. 
 
Yoo, B. C., Seidl, R., Cairns, N. and Lubec, G. (1999). Heat-shock protein 70 levels in 
brain of patients with Down syndrome and Alzheimer´s disease. J. Neural. Transm. 
Suppl. 57, 315-322. 
 
Zhang, Y., McLaughlin, R., Goodyer, C. and Leblanc, A. (2002). Selective 
cytotoxicity of intracellular amyloid beta peptide 1-42 through p53 and Bax in 
cultured primary human neurons. J. Cell Biol. 156, 519-529. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
75 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
7. ANNEXES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                 The effect of cellular stress on APP 
 
  
 
 
 
76 
Bellow is listed the equipment used and composition of buffers for the 
different techniques applied. 
 
7.1 For cell culture and experimental models 
 
Equipment 
  Hera cell CO2 incubator (Heraeus) 
  Safety cabinet Hera safe (Heraeus) 
  Inverted optical microscope (LEICA) 
  Hemacytometer (Sigma) 
  Sonicator U200S (IKA) 
  Bath SBB6 (Grant) 
 Reagents 
  Dulbecco’s modified Eagle’s medium (DMEM; Sigma) 
  RPMI 1640(GIBCO BRL) 
  Foetal bovine serum (GIBCO BRL) 
  Horse serum (GIBCO BRL) 
  Antimycotic-antibiotic solution (GIBCO BRL) 
  Trypsin-EDTA (GIBCO BRL) 
  Poly-L-ornithine (Sigma) 
  NaHCO3  (Sigma) 
  Abeta 1-40 and Abeta 25-35 (Sigma) 
  2-deoxyglucose (2DG) (Calbiochem) 
  Sodium azide (NaN3) (Merck) 
  Phosphate buffer saline (PBS) (Pierce) 
  AO (Calbiochem) 
  PMA (Calbiochem) 
 
 
7.2 For measurement of cell viability 
 
Equipment 
  Spectrophotometer Cary 50 (Varian) 
 Reagents 
MTT [3-(4,5dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] 
(Sigma) 
  Acidic isopropanol (0.04 M HCl in absolute isopropanol) 
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7.3 For protein content determination 
 
Equipment 
  Spectrophotometer Cary 50 (Varian) 
 Reagents 
  BCA assay kit (Pierce, Rockford, IL) 
  Bovine serum albumin (BSA) (Pierce) 
Working reagent (Reagent A: sodium carbonate, sodium 
bicarbonate, BCA and sodium tartrate in 0.2 N sodium hydroxide; 
reagent B: 4% cupric sulfate). 
 
7.4 For SDS-PAGE 
 
Equipment 
  Electrophoresis system (Hoefer SE600 vertical unit) 
  Electrophoresis power supply EPS 1000 (Pharmacia Biotec) 
Reagents 
Acrylamide stock mixture (30% acrylamide, 0.8% N,N’-
methylenediacrylamide) 
Stacking gel (H20, 30% acrylamide mixture, 4x stacking gel buffer 
(0.63 M Tris, pH 6.8), 10% SDS, 10% ammonium persulfate, TEMED) 
Resolving gel (H20, 30% acrylamide mixture, 4x resolving gel buffer 
(1.5 M Tris-HCl, 0.014 M SDS, pH 8.8), 10% ammonium persulfate, 
TEMED) 
  10x Running Buffer (0.25 M Tris-HCl, 1.92 M Glycine, pH 8.3, 0.1% SDS) 
4?  SDS gel-loading buffer (250 mM Tris-HCl pH 6.8, 8% SDS, 0.01% 
bromophenol blue, 20% 2-mercaptoethanol, 40% glycerol) 
Kaleidoscope/prestained SDS-PAGE standards (Bio-Rad) 
 
7.5 For Western blotting 
 
Equipment 
  Transphor Electrophoresis unit (Hoefer TE 42) 
Electrophoresis power supply EPS 1000 (Amersham Pharmacia 
Biotech) 
Reagents 
Transfer buffer (0.025 M Tris base, 0.19 M Glycine, 20% methanol, pH 
8.3) 
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7.6 For immunodetection of proteins 
 
Reagents 
10x Tris-buffered saline (TBS) (0.1M Tris, 11.5M NaCl, pH 8.0) 
10?  Tris-buffered saline Tween (TBS-T) stock (0.1M Tris, 11.5M NaCl, 
0.5% Tween 20, pH 8.0) 
Blocking solution (5% nonfat dried milk in 1x TBS-T) 
  ECL or ECL Plus Kits (Amersham Biosciences) 
Developer and fixer solution (Sigma) 
Bromocloroindolyl phosphate/nitro blue tetrazolium (BCIP/NBT) 
(Promega) 
Alkaline phosphatase buffer (100mM NaCl, 100mM Tris (pH 9.5), 5mM 
MgCl2) 
Substrate solution (66? l of NBT in 10ml of alkaline phosphatase buffer, 
mix and add 33? l of BCIP) 
Stop solution (20mM Tris, pH 9.5, 5 mM EDTA) 
 
7.7 For statistical analysis 
Equipment 
  GS-710 calibrated imaging densitometer (Bio-Rad) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
